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ABSTRACT 
 
 
AMY MARIE KNAB.  The role of the dopaminergic system in the regulation 
of physical activity in mice.  (Under the direction f DR. TIM LIGHTFOOT) 
 
 
 Physical activity (PA) is important to human health, and the genetic and 
biological regulating factors of physical activity are only beginning to be understood.  
The dopamine (DA) system has been shown to regulate mo ivation, and locomotor 
behavior in animals, and this research was designed to understand the dopaminergic 
factors important in regulating voluntary physical activity in mice.  First, the 
repeatability of measuring exercise endurance vs. wheel running (WR) in different 
inbred strains of mice was investigated.  It was found that WR behavior is a highly 
repeatable measurement, while exercise capacity measurements showed low 
repeatability in Balb/cJ mice.  Next, expression leve s of the five DA receptors, 
Tyrosine hydroxylase (TH), and the dopamine transporter (DAT) in the nucleus 
accumbens and striatum were studied in mice with or without wheel access in 
differentially active inbred strains of mice.  No differences in expression levels of any 
DA receptors were found within strain between group, suggesting level of PA did not 
affect DA receptor expression.  High active C57L/J mice had significantly decreased 
expression of Drd1 and TH compared to low active C3H/HeJ mice indicating DA 
receptor, and enzyme expression/function may act independently to control level of PA.  
Pharmacological studies showed C57L/J mice significantly decrease WR in response to 
a D1 agonist, and C3H/HeJ mice significantly increase WR in response to a DAT 
inhibitor.  These results suggest genetic differences in the DA system may mediate 
differences in PA behavior between inbred strains of mice. 
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INTRODUCTION 
 
 
  Physical inactivity has become more prevalent in today’s society because 
technological advances have enabled people of Western cultures the freedom to do less 
work to accomplish the activities of daily living.  Before industrialization, daily living 
still required a good degree of physical activity (22).  Even though technological 
progress can be argued to have significantly advanced society, the burdens of physical 
inactivity can be experienced in other arenas, including human health (180).  Lack of 
physical activity has been linked to the rising rate of obesity (297), and it is well known 
that regular physical exercise can improve the risk of heart disease (82), certain types of 
cancer (251), and depression (58, 134, 248).  Thus, understanding the genetic and 
environmental factors regulating the amount of voluntary physical activity performed 
by a given individual is crucial to improving human health and standard of living, 
especially in Western cultures where physical activity s not necessarily required in 
daily living activities. 
 Environmental factors involved in physical fitness have been well studied (67, 
281).  However, genetic and non-genomic biological factors affecting voluntary 
physical activity have only recently begun to be studied, and are not well understood.  
Studies have shown that inheritance of physical activity raits in mice is anywhere from 
20-80% (69, 119, 135, 149, 249, 262).  The fact that t ere is a genetic component to 
physical activity behavior is no surprise; however, the actual genes regulating these 
behaviors have yet to be fully discovered and understood.  Lightfoot and colleagues 
(2008) (153), investigated possible quantitative trait loci (QTL) [QTL are simply areas 
of the genome that are associated with a given trait] involved in physical activity 
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(distance, duration, and speed on a running wheel) in mice and found one significant 
QTL for distance, duration, and speed on chromosome 13, and one significant QTL for 
speed only, on chromosome 9 (138, 153).  This work was expanded by Leamy and 
colleagues (138), in which it was found that single-locus QTL as well as epistatic 
interactions [epistatic interactions occur when onegene’s action is affected by another 
gene] account for approximately 37-60% of the total variation between activity traits in 
mice.  Thus, epistatic gene interactions may also play a major role in the genetic 
regulation of physical activity behavior in mice.  Additionally, there have been early 
gene linkage studies in humans that have sought to find genes involved in fitness and 
performance phenotypes (193).  Interestingly, several of the identified QTL in the 
animal models and at least one human study (235) have suggested the involvement of 
the dopamine system in the genetic/biological regulation of physical activity. 
 Recent evidence in animal studies has suggested a possible role of the dopamine 
system in regulating voluntary physical activity levels (29, 199-201).  The dopamine 
system is an interconnected neuronal network located in the central nervous system that 
is primarily mediated by signaling from the neurotransmitter dopamine.  Dopaminergic 
signaling in various areas of the brain is responsible for a wide array of functions 
including control of motor movement, motivation, reward, learning, and emotion (240).  
Malfunctions of the dopaminergic system are thought to be the cause of movement 
abnormalities manifested in Parkinson’s disease pati nts, hyperactive behavior in 
Attention Deficit Hyperactivity Disorder, addictive behavior with drugs of abuse, and 
even behavioral abnormalities in eating disorders such as anorexia.  It is therefore 
evident that the dopaminergic system has a clear independent relationship with 
    ix
 
locomotor and motivational behavior; however the exact role of the dopamine system in 
regulation of voluntary physical activity is not known. 
 It is known that physical exercise causes changes in neurotransmitter systems 
such as the dopamine system.  Specifically, depending on exercise intensity and 
duration, there is an acute rise in dopamine production (166), and theoretically 
dopamine signaling.  In this case, dopamine signaling is a dependent variable, changing 
in response to exercise intensity and duration.  However, recent evidence suggests that 
the dopamine system may also play an independent role in regulating physical activity 
levels in animals.  The effects of dopaminergic acting drugs have been studied for their 
effects on locomotion in animals (70, 90, 92, 93, 121- 23, 163, 191, 192, 211, 223, 226, 
242, 260, 261, 275).  Several studies have also shown locomotor response to 
dopaminergic drugs to be strain dependent (29, 56, 70, 191, 228, 238, 261) suggesting 
genetic differences in dopaminergic architecture and fu ction between inbred strains of 
mice may mediate differences in locomotion response to dopaminergic drugs.  This 
notion also suggests some of the genes involved in regulating physical activity may be 
located within the dopaminergic system.  Interestingly, the suggestive QTL (post 
Haplotype analysis) on chromosome 13 found in Lightfoot’s work contains Drd1, the 
gene which codes for the D1 receptor (153).  Similarly, polymorphisms in the Drd2 
gene are associated with physical activity levels in white women (235).   
 The work done in locomotion experiments must be considered with care because 
there are many different methodologies and definitio s of locomotor behavior in animal 
literature.  Locomotion is generally defined as the act of movement, and animal 
locomotion is the study of how animals move.  Thus, interpretation of general 
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locomotor behavior, although useful, is difficult in regard to understanding the role of 
the dopamine system in regulation of v luntary physical activity.  Physical activity is 
generally defined as voluntary movement that signifcantly increases energy 
expenditure as well as increases fitness.  Wheel running in animal models has been 
shown as a good measurement of voluntary physical activity, and is also suggested as a 
good correlate to human physical activity and/or exercise (61).  Several experiments 
using mice selectively bred for high wheel running have sought to find the genetic 
differences causing the increased physical activity n selected animals compared to 
control line mice (29, 59, 84, 85, 199-201, 253, 255, 257).  From these selective 
breeding experiments, though some peripheral differences do exist, a significant central 
component has been suggested as an important factorin mediating differences in wheel 
running (29, 200).  Specifically, differences in the dopamine system have been 
identified in selectively bred mice for high wheel running, and these differences may act 
independently to regulate motivation for wheel running in the selected animals (198, 
199). 
 Any trait is determined by the following set of variables: 
Phenotype = genetic component + environmental component + interaction 
In the case of physical activity, environmental factors are well known, but the possible 
genetic components have yet to be elucidated.  Work d ne recently suggests that a 
significant central component, the dopamine system, may be an important genetic factor 
in the regulation of physical activity (29, 199-201).  However, it is not known whether 
the dopamine system acts as an independent variable in th  regulation of voluntary 
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physical activity, and if there is an independent mechanism, which dopaminergic genes 
may be involved in the regulation of physical activity.   
 In the following chapters, several studies will be addressed that attempted to 
determine the role of the dopaminergic system in regulation of physical activity. 
Chapter 1 contains an extensive literature review of the investigations that point toward 
a possible role of the dopamine system in regulation of physical activity (this chapter is 
currently in review for publication in International Journal of Biological Sciences).  In 
Chapter 2, the repeatability of exercise behaviors wa assessed using inbred mice to 
ensure measurement of wheel running was a repeatabl phenotype and also examined 
the repeatability of treadmill exercise in mice.  In this study it was found that in male 
and female Balb/cJ mice, wheel running behavior is a highly repeatable measure, while 
endurance treadmill testing is not repeatable (thisc apter is currently in review for 
publication in Physiology & Behavior).  Chapter 3 outlines a study that was designed to 
investigate whether the dopamine system acted in andependent fashion to regulate 
physical activity in inbred mice.  Also, in this chapter, expression levels of seven vital 
dopaminergic genes in the nucleus accumbens/striatum rea of the brain were analyzed 
to determine if expression of any dopaminergic receptors, transporter, or enzymes were 
different between differentially active inbred strains of mice.  In this study we found 
that dopaminergic gene expression did not differ within strain, between mice with 
access to a wheel and mice without a wheel, suggestin  there was no dependent 
mechanism through which wheel running affecting expr ssion levels of the genes 
studied.  However, significant differences were found between high active C57L/J mice 
and low active C3H/HeJ mice.  High active mice exprssed significantly lower amounts 
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of Drd1 and tyrosine hydroxylase compared to low active mice, suggesting the 
dopamine system may be an independent variable in the regulation of physical activity 
(this chapter is currently in review for publication in Behavioural Brain Research).  
Finally, in Chapter 4, pharmacological studies were employed to confirm whether 
differences in expression of dopaminergic genes actually led to alterations in voluntary 
physical activity.  This study sought to identify how genetic differences in the dopamine 
system between inbred strains of mice altered wheel running response to 
pharmacological agents.  It was found that high active mice significantly reduced wheel 
running in response to a D1 agonist, while C3H/HeJ mice significantly increased wheel 
running in response to a dopamine re-uptake inhibitor, confirming that genetic 
differences in dopaminergic functioning may explain differences in physical activity 
levels in inbred strains of mice (this chapter is currently in review for publication in 
Behavioural Brain Research). 
 While these experiments were designed to determine whether dopaminergic 
functioning played a role in the regulation of physical activity, it is important to 
mention that dopaminergic signaling does not occur in isolation, and is affected 
biologically by other factors such as hormones, nutritional status, and exercise intensity.  
Thus, future studies will need to consider other factors to further investigate the genetic 
mechanisms of dopaminergic regulation of physical ativity, and how this system can 
be altered biologically in order to improving motivation for physical activity and overall 
human health.   
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CHAPTER 1: LITERATURE REVIEW 
DOES THE DIFFERENCE BETWEEN PHYSICALLY ACTIVE AND COUCH 
POTATO LIE IN THE DOPAMINE SYSTEM? 
 
 
Introduction 
Voluntary physical activity is important to human health for many reasons, 
including the prevention of obesity (38, 224).  The rate of obesity has steadily increased 
over the last 30 years (294), while at the same timhe amount of voluntary physical 
activity has decreased (1).  Increases in sedentary lifestyles in Western cultures has led 
to an increase in inactivity related diseases such as obesity, cardiovascular disease, Type 
II Diabetes, and certain types of cancer (189).  Research has shown the benefits of 
physical activity to human health and its importance in increasing resting metabolic rate 
(241), prevention of certain types of cancer (18), prevention of age related muscle loss, 
or sarcopenia (54), and treatment of depression and anxiety (52).  Although the 
physiology of exercise has been well studied, the factors controlling physical activity 
levels in humans are not fully understood.  Thus, it i  important to understand the 
regulating factors of voluntary physical activity in order to prevent inactivity related 
diseases and improve human health. 
Biological Influence on Physical Activity 
 The manifestation of a particular phenotype (in ths case voluntary physical 
activity level) is traditionally thought to be determined by the following equation:
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Phenotype = environment + genetics/biological factor + environment/genetic interaction).   
The relative contribution of each of these components differs depending on the 
phenotype in question.  Several recent genetic studies have investigated the level of 
genetic association with physical activity in humans d in animal models.  The 
estimated genetic component for physical activity from these studies ranges from 20-
80% (69, 119, 135, 142, 149, 153, 184, 249, 262). Additional support for the genetic 
component of voluntary physical activity can be found in mice selectively bred for high 
wheel running activity (253).  Even after just 10 generations of selective breeding for 
high wheel running, selected animals exhibited a 75% increase in wheel running 
activity (253). and after 35 generations selected anim ls ran 170% more than controls 
(197).  Recently, Lightfoot et al. (2008) conducted single-gene quantitative trait loci 
(QTL) analysis to determine the genetic locations po sibly involved in regulation of 
physical activity.  QTL analysis allows for the investigation of specific areas of the 
genome that are associated with a given trait.  Using three wheel running indices in 
mice as indicative of physical activity, one significant QTL for distance (Chr. 13), one 
significant QTL for duration (Chr. 13), and two sign ficant QTL for speed (Chr. 13 and 
9) were found, confirming a genetic component to the regulation of voluntary physical 
activity in mice (153).  Further work from this group (138), in combination with the 
initial QTL analysis, showed that in the inbred F2 model used, the single-gene and 
epistatic [gene-gene interactions] QTL together accounted for 84-100% of the 
genetically-related phenotypic variance.  
 Where does the genetic/biological regulation occur? 
The site of action of possible genetic/biological components affecting physical 
activity may include either peripheral locations and mechanisms (e.g. fiber type, 
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number of mitochondria, cell metabolism components, oxygen consumption etc.), 
and/or central locations and mechanisms (e.g. brain signaling, neurotransmitters, 
motivational behaviors etc.).  Interestingly, work done with animals selectively bred for 
high wheel running, has shown very few and/or minimal peripheral differences between 
mice selected for high wheel running, compared to control mice (59, 124, 196, 197, 
255, 257, 264, 265).  Peripheral differences alone cannot explain the huge differences in 
wheel running between selectively-bred high active mice and control mice suggesting 
that a significant portion of the genetic/biological omponent affecting physical activity 
likely comes from central factors.  This hypothesis i  upported by several studies.  
First, mice selectively bred for high activity had increased Brain Derived Neurotrophic 
Factor (BDNF) in the hippocampal area of the brain compared to control mice (118).  
Rhodes and colleagues also showed that mice selected for high wheel running had 
increased activity as measured by Fos immunoreactivity in specific areas of the brain 
including the mid-brain (200).  Finally, Bronikowski et al. (2004) showed that mice 
selected for high wheel running had a 20% increase in dopamine 2 (D2) and dopamine 
4 (D4) receptors in the hippocampus as compared to control line mice (29).   The gene 
array used in this study did not contain the D1-like receptors, and the hippocampus is 
not known as a brain region mediating dopaminergic mediated motivation and reward, 
however the authors still suggested the data indicate a possible role of the dopamine 
system to an increased motivation to run in selected mice (29).    Furthermore, given the 
fact that selected mice and control line mice respond similarly to D2-like antagonists 
(199), but respond differentially to D1-like antagonists suggests the D1-like receptors, 
and not the D2-like receptors, in certain areas of mid-brain are important in activity 
 4 
 
regulation in selectively bred high active mice (199, 200).  The results from studies on 
the central nervous system in the selectively bred mice are summarized in Table 1. 
 Supporting the hypothesis that the dopaminergic system is an appropriate 
genetic/biological candidate in the central control of voluntary physical activity are 
studies that have implicated dopamine functioning in the control of motor movement 
(213), reward (225), learning, motivation (181), and emotion (233).  However, to this 
point, the majority of studies investigating physical activity in humans have treated 
changes in neurotransmitter systems, such as dopamine, as a dependent factor that 
responds to physical activity stimuli such as intensity or duration of exercise.  Similarly, 
work done in animals has for the most part employed research designs focusing on 
neurotransmitter systems and “locomotion” in relation to diseases such as Parkinson’s 
disease.  However, extensive recent evidence presented by Garland and colleagues (29, 
198-201) with mice selectively bred for high activity indicated a strong central 
component that may act in an independent fashion; i.e. the central component may 
control physical activity levels as part of a genetic/biological regulation scheme.  This 
paper will review the literature implicating the dopaminergic system as an independent 
regulator of locomotion in animals, as well as the emerging effort to understand the role 
the dopamine system plays in the regulation of voluntary physical activity.  A novel 
interpretation of the central biological regulation f voluntary physical activity with 
respect to the dopaminergic system will also be presented. 
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The Dopaminergic System 
 While an exhaustive review of the structure and function of the dopaminergic 
system is beyond the scope of this review, in order to place the potential function of the 
dopamine system within the context of the central regulation of physical activity, a short 
overview of the dopamine system is necessary.  
The dopaminergic neurons in the brain originate from two distinct areas.  The 
neurons originating from the substantia nigra pars compacta project into the dorsal 
striatum via the nigrostriatal tract (100), while those neurons originating from the 
ventral tegmental area project into the cortex and ventral striatum (nucleus accumbens) 
via the mesolimbic tract (60, 145).  The dopaminergic neurons interconnect with many 
areas of the brain leading to the implication of the dopaminergic system in many central 
functions including reward, learning, motivation, response to stimuli, and movement 
(240).  Figure 1 illustrates the important dopaminergic pathways in the brain.  
Potentially important for the regulation of physical activity is the striatum/nucleus 
accumbens area given this area is involved in motivation, reward, and motor movement. 
 There are two evolutionarily and genetically different subtypes of receptors for 
dopamine within the dopaminergic system, and a total of five known distinct receptors 
(34, 240).  The dopamine D1-like receptor family includes the dopamine one (D1) and 
dopamine five (D5) receptors.  These receptors contain o introns, act by way of Gs-
proteins, and activate adenylyl cyclase, thus increasing cAMP production (139, 268).  
The D-2 like receptor family includes the dopamine two (D2), dopamine three (D3), 
and dopamine four (D4) receptors.  These receptors contain introns, act via Gi-proteins, 
inhibit adenylyl cyclase activity, and thus decrease cAMP activity (139, 170).  The two 
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dopamine receptor families do not appear to act in isolation however, because it has 
been shown that activation of D1 receptors in the rat striatum causes D2 receptors to 
shift to a “low binding state” for dopamine (229).  Likewise, D1 and D2 receptors have 
been shown to physically interact in certain areas of the brain, possibly working 
synergistically to affect downstream signaling (60).  Thus, the different dopamine 
receptors do not act independently; instead signaling from each of the dopamine 
receptors appears to affect the other dopamine receptors making the dopamine system a 
complicated signaling network.     
 Dopamine receptors differ in their anatomical locations on specific neurons, 
vary in density in specific regions of the brain, ad can be found either presynaptically 
or postsynaptically depending on the type of tissue and/or neuron (170).  The 
distribution of dopamine receptors in the brain is diverse; however, specific dopamine 
receptors are differentially expressed at higher or lower levels in particular areas of 
brain (60), exemplifying the complexity of the dopamine system.  Dopamine receptor 
expression is found in nearly all areas of the brain, but receptors are most highly 
expressed in nigrostriatal and mesolimbic regions including the striatum, nucleus 
accumbens, and cortex (48, 114).  The five known dopamine receptors differ in their 
affinity for dopamine, natural ligands, receptor activity, anatomical locations, genetic 
sequence, and thus, physiological activity (34); however, the dopamine receptors work 
in concert with each other to produce integrated responses and signals in the brain and 
body. 
 Expression levels of the dopamine receptors are important in mediating 
downstream behavioral responses including voluntary activity.  Dopamine receptor 
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expression can be affected by the levels of dopamine in the system (90), level and 
length of treatment of pharmacological agents (31), as well as other external stimuli 
mediated through rewarding behavior such as sexual activity (167), or exercise (74).  
However, overall dopaminergic responses and signaling re also dependent on other 
factors such as the electrical response produced (dopamine signaling can act in both an 
excitatory manner, as well as an inhibitory manner depending on the circumstance) (36, 
106, 145), as well as interactions with other neurotransmitters and signaling molecules.  
For example, the dopamine system has been shown to interact with glutamate (231), 
GABA (94), acetylcholine (221), and serotonin (64).  Depending on the receptor 
involved and the anatomical location, dopamine receptors activate or repress a variety 
of signaling cascades including ERK/MAPK (156), CREB (204), and CAMKII (110), 
by affecting calcium and/or potassium channels in the nerve cell (170).  A 
representative dopaminergic synapse is shown in Figure 2.  Only possible signaling 
pathways for the D1-like receptors are illustrated.  Possible signaling pathways in the 
dopaminergic neurons are extensively reviewed by Neve and colleagues (2004) (176). 
 Dopamine receptor signaling also affects downstream gene expression (170).  
Several immediate early genes that are activated in dopaminergic neurons following 
stimulation include those of the Fos family (107, 15, 200, 283). Fos is a transcription 
factor that is up-regulated in certain brain regions in response to stimulation from drugs, 
or other natural rewarding stimuli such as sexual behavior or exercise (200, 236).   Fos 
is the product of the immediate early gene c-Fos, and Fos expression has been shown to 
be regulated by dopamine signaling (206).  Pharmacological studies show that Fos 
immunoreactivity in the striatum and other key regions of the brain is increased 
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following administration of D1 and D2 agonists (97, 109, 115, 178, 205), suggesting 
Fos may be important as a downstream gene regulated by dopaminergic signaling.   
∆FosB, a transcription factor and also a member of the Fos family of proteins, is 
likewise up-regulated in response to drugs of abuse and exercise.  The expression of 
∆FosB is usually longer lasting than Fos, and is thoug t to be involved in long term 
changes in behavior (175, 283).  Brain Derived Neurotrophic Factor (BDNF) also 
appears to be regulated in part by dopamine signaling nd has been shown to increase as 
a result of physical exercise (68).  Additionally, it is thought that the antidepressant 
effect of exercise is mediated through the dopamine system, and increased expression of 
BDNF (63). 
Thus, while Fos and BDNF are two examples of downstream transcription 
factors regulated by dopamine signaling, the dopamine system potentially affects a large 
number of downstream genes that may ultimately be important in the understanding of 
the genetic mechanisms involved in regulation of physical activity levels in animals and 
humans.   
Fore example, dopamine signaling has also been shown to have direct affects on 
expression levels of certain neuropeptides including substance P (SP) (88), dynorphin 
(12, 76, 246), and enkephalin (136, 247).  In addition o other functions, these 
neuropeptides can in-turn also modulate other gene expression and downstream 
signaling, highlighting the possible indirect effects of dopamine signaling on 
downstream gene expression changes.  A detailed description of the interaction of 
neuropeptides and dopamine signaling is beyond the scope of this review; however, the 
point should be made that any regulation of voluntary physical activity by dopamine 
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signaling may be mediated through not only dopamine rec ptor expression levels, but 
also downstream signaling pathways including those that affect expression of 
transcription factors and other neuropeptides known to affect transcription and gene 
expression.  Therefore, there are many aspects of the dopaminergic system, including 
expression of receptors, interaction with other neurotransmitters and signaling 
molecules, and downstream gene regulation that may be important in the 
genetic/biological regulation of voluntary physical activity. 
Dopaminergic Regulation of Locomotion:  Evidence from Human Disease States 
 Extensive studies have been conducted to assess the role of the dopamine 
receptors and the dopamine system in various behavioral functions (116, 290).  
Literature investigating disease states such as Parkinson’s disease is available which 
emphasizes the role of the dopamine system in regulation of motor movement and/or 
“locomotion”.  It is important therefore, to make the distinction between “locomotion” 
and “physical activity”.  The term locomotion in scientific literature generally refers to 
any act of movement, which depending on methodology, can operationally differ 
significantly between studies.  Conversely, physical a tivity is generally defined as 
purposeful exercise and/or movement that expends a significant amount of energy.   
While there are slight differences between operation l definitions of locomotion and 
physical activity which are highlighted later in this review, it is still important to 
highlight the known dopaminergic involvement in locomotion to understand the 
possible role the dopamine system might play in regulating physical activity, especially 
since the preponderance of the available literature deals with ‘locomotion’ in disease 
states rather than physical activity.   
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 Four major areas of disease research support a role of the dopamine system in 
the regulation of physical activity through control of motor movement and motivation 
including Parkinson’s Disease, Attention Deficit Hyperactivity Disorder (ADHD), 
Anorexia, and Addiction.  An overview of the role of the dopamine system in these four 
disease states is outlined in Table 2. 
Parkinson’s Disease 
 One area that has specifically highlighted the rolof the dopamine system in the 
regulation of locomotion is Parkinson’s Disease.  Common characteristics of 
Parkinson’s Disease include resting tremors, bradykinesia, rigidity, and overall 
difficulty in motor movement as a result of degradation and subsequent loss of 
dopaminergic neurons in the substantia nigra area of the brain (5, 301).   Although the 
exact mechanisms that result in loss of dopaminergic neurons in Parkinson’s disease are 
not well understood, it appears that misfolding and/or inherited mutations of the 
proteins alpha-synuclein and ubiquitin play an important role in the onset of the disease 
(125, 143, 160).  Two types of animals models of Parkinson’s symptoms give insight 
into the importance of the dopamine system in locomot r behavior.  Toxin-induced 
models of Parkinson’s commonly involve the use of 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (MPTP), a toxin which when administered causes malfunction and 
loss of dopaminergic neurons in the brain.  When MPTP is administered to mice, 
reduced locomotor function is evident through various tests including open field (228), 
and rotarod assessment (209).  Interestingly, there app ar to be strain differences in 
susceptibility to MPTP and this may be caused by genetic differences in the dopamine 
system between different strains of mice (103, 228).  The second type of animal model 
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involves transgenic animals which either overexpress specific genes, or have genes 
“knocked out”, and thus, do not express a particular gene involved in Parkinson’s 
disease.  Dopamine D2 receptor knock-out mice (11), as well as hybrid D1 receptor 
transgenic/D2 receptor deficient mice (55), display P rkinson’s-like locomotor 
behavior; however, mice that have been genetically altered in some aspect of 
dopaminergic signaling usually display global behavioral changes, and thus are not 
ideal for studying specific aspects of locomotion in most cases.  Regardless, it is clear 
from Parkinson’s disease literature that the dopamine system plays a major role in 
motor deficiencies manifested in this disease.   
Attention Deficit Hyperactivity Disorder 
 Another important line of evidence supporting the involvement of the 
dopaminergic system in regulation of voluntary physical activity is its well studied role 
in Attention Deficit Hyperactivity Disorder (ADHD) (8, 144).  ADHD usually presents 
in childhood, but can also persist into adulthood (243), indicating that the central 
functioning mediating the symptoms may sometimes be irreversible.  Genetic 
alterations of both the D4 and D5 receptors have been implicated as primary 
mechanisms in ADHD.  Drd4 polymorphisms have been found in both human and 
animal models of ADHD (169).  Additionally, inheritance studies suggest an increased 
risk of ADHD associated with particular alleles (alternative forms of a gene) ofDRD4 
and DRD5 (8, 65, 147).  Moreover, inheritance and allelic variant studies show an 
association between DAT , the dopamine transporter gene which is involved in 
transporting dopamine back into the neuron after it has been released into the synapse, 
and ADHD (65, 78).  However, the most compelling evid nce regarding dopaminergic 
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involvement with ADHD comes from pharmacological studies.  Stimulants which block 
DAT, resulting in increased synaptic dopamine levels, have been shown to significantly 
reduce the hyperactive symptoms of ADHD (159, 286-28).  The dopamine transporter 
(DAT) has been shown to be important in the control of many aspects of locomotion 
(81).  The dopamine transporter is a key regulator of the dopamine system as it 
regulates the amount of dopamine signaling taking place with all the receptors.  A 
complete review of the role of DAT in locomotion and parkinsonism can be found by 
GR Uhl, Movement Disorders, 2003 (263).  
 Mice exhibiting high amounts of wheel running after many generations of 
selective breeding have been suggested as a potential model of ADHD (269).  Garland 
and colleagues have shown that these selectively-brd mice have altered dopamine 
profiles compared to control line mice, as well as responding more profoundly to 
dopaminergic acting drugs such as dopamine transporter inhibitors, suggesting similar 
mechanistic pathways as ADHD (200, 201).   It has been suggested the selectively bred 
mice from Garland’s group are a good model for ADHD (199), but they may also 
provide insight into the dopaminergic regulation of v luntary physical activity in mice. 
Anorexia 
 Previous studies have suggested that the dopamine syst m is involved in 
regulation of feeding behavior in animals (182).  In addition, recent studies have begun 
to investigate the increase in activity that results from the starvation characteristics of 
anorexia nervosa, which is sometimes labeled the “drive for activity” (35).   Typically, 
reported symptoms of semi-starvation include slowing of motor movement and 
lethargy; however, in a significant percentage of anorexia nervosa patients quite the 
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opposite is observed with anorexic patients exhibiting increased physical activity levels 
(26, 117).  In 2006, Davis and Kaptein suggested that anorexia nervosa patients who 
exhibit “excessive exercising” represent a subtype of the disorder closely linked to 
obsessive compulsive disorder (45).  Whether the exc ssive exercising in a subgroup of 
anorexia patients represents co-manifestation of OCD is still controversial; however, the 
role of the dopamine system in mediating this behavior is relevant to this review.  
Several monoamine neurotransmitters including norepinephrine, serotonin (9), as well 
as dopamine have been suggested to play a role in this increased motivation for activity 
in anorexia nervosa (188).  In animal models of “activity induced anorexia” the 
dopaminergic system is suggested as a mediator of the increased physical activity seen 
in this disorder (86, 188).  Although the exact mechanism is still unclear, it has been 
shown that exercising intensely increases dopaminergic reward signaling (28), and 
subjects with anorexia may exercise excessively in order to relieve the “anhedonic 
state” created by insufficient nutrition (46, 75).  Similarly, in a report by Frisch et al. 
(2001), it was reported that a polymorphism in the Catechol-O-methertransferase gene 
(COMT) was associated with risk of developing anorexia in humans (80).  This gene 
confers an enzyme important for dopamine catabolism, and further suggests a role of 
the dopamine system in manifestation of anorexia.  Additionally, Frank et al. (2005) 
studied dopamine D2/D3 receptor binding in the brain in women recovering from 
anorexia.  Compared to controls, women with anorexia showed increased dopamine 
receptor binding in the striatum, and this suggested that decreased synaptic dopamine, 
or increased receptor expression may be associated with certain phenotypic 
characteristics of anorexia including increased physical activity (75). 
 14 
 
Addiction 
 A complete review of the physiological underpinnings of addiction is beyond 
the scope of this review; however, it is well accepted that the dopamine system is a 
major mediator of addiction to drugs (reviewed extensively in Vetulani, 2001; Peirce 
and Kumaresan, 2006; and Di Chiara, 2007) (50, 187,271).  Specifically, the dopamine 
reward centers are known to involve the neurons in the ventral tegmental area which 
project into the nucleus accumbens and other forebrain regions.  It has been 
hypothesized that people who are addicted to such things as risky behavior, drugs, and 
gambling may have genetic differences in their dopamine system that predispose them 
to such behavior (272).  This hypothesis has been supported by results investigating the 
administration of methylphenidate (a psychoactive drug) to non-drug users whose D2 
receptor expression was high in the brain.  The administration of methylphenidate to 
these subjects produced a feeling of aversion, as opposed to what happened when 
methylphenidate was administered to people with low levels of D2 receptor expression; 
in these subjects the drug produced a pleasure feeling (273).  Studies in animals also 
suggest a genetic component involving the dopamine system in the mechanism of 
addiction.  For example, it has been found that C57BL/6J mice have increased 
expression of D1 and D2 receptors in the striatum co pared to DBA/2J mice, and these 
differences are associated with ethanol preference in these mice and possible strain 
differences in tendency for alcohol addiction (177).  Additional evidence in rodents has 
suggested both D1-like and D2-like dopamine receptors, and the dopamine transporter 
gene may be a mediator in addictive behavior (87, 101 242).  These results can be used 
to hypothesize that the dopaminergic system may play a role in the pleasurable feelings 
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associated with voluntary physical activity in humans and thus, might contribute to the 
observed variation in animals and humans in motivation for physical activity.  
Evidence for dopaminergic involvement in locomotion alterations in diseases 
such as Parkinson’s disease and ADHD, physical activity and the drive to exercise in 
Anorexia patients, as well as possible pleasure-fulfillment in addiction suggests that not 
only does the dopamine system regulate “motor movement” in the strict sense (see 
Table 2), but may also regulate motivational factors such as rewarding/pleasurable 
feelings involved in physical activity phenotypes.   
Dopaminergic regulation of Physical Activity:  Evidence from animal models in 
 locomotion and wheel running studies 
 
Locomotion Studies 
 The psychoactive drugs amphetamine and cocaine have been known to induce 
rewarding effects mediated through the dopamine system.  Drug affects on locomotion 
through dopaminergic changes is relevant to this review because natural rewarding 
behaviors such as sexual behavior have also been shown to produce their effects 
through increased dopamine production in the midbran (44).  It can be argued that 
physical exercise is a naturally rewarding behavior as well, and the mechanism of this 
rewarding behavior may be important in the dopaminergic regulation of physical 
activity.  Thus, to further illustrate the importance of the dopamine system in mediating 
locomotor behavior in animals it is necessary to briefly review both pharmacological 
studies, as well as studies using transgenic and/or knock-out mice investigating the 
effects of the dopamine receptors, as well as the dopamine transporter in mediating 
locomotion in animals. 
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 A major pool of literature can be found linking the dopamine system to 
locomotor changes induced by psychoactive drugs (14, 16, 90-92, 97, 108, 123, 211, 
223, 242, 296).  For example, it has been shown that the dopamine system mediates 
differences in amphetamine induced locomotion betwen inbred strains of mice (270).  
The majority of studies involving amphetamine and locomotion implicate an increase in 
dopamine levels in the mid-brain as the main factor mediating the locomotor response 
to amphetamine (16, 51, 92), while studies also suggest this response is mediated 
downstream by BDNF (223).  Similar studies using cocaine have implicated specifically 
the dopamine D1 receptors (299), as well as blockade of DAT (260), as being involved 
in mediating the cocaine induced changes in locomotion in animal models.   
 D1 and D2 receptors have been studied extensively in pharmacological studies 
investigating their role in locomotor behavior in aimals with 3,4-Methylene-
dioxymethamphetamine (MDMA) used as the primary stimulant increasing locomotion 
(91). When mice are pre-treated with a D2 receptor antagonist (eticlopride, 0.2mg/Kg), 
the locomotion response to MDMA was non-existent, while pre-treatment with a D1 
antagonist (SCH-23390, 0.2mg/Kg) did not abolish the MDMA induced locomotion but 
did delay the onset of this effect.  These results suggest that both D1 and D2 receptors 
are important in stimulant induced locomotion, yet s rve different functions in this 
response (14).  The suggestion of an important role for the dopaminergic receptors in 
the modulation of locomotion have been further confirmed by other pharmacological 
studies investigating the D1-like and D2-like receptors (171, 174, 244, 245).   
Quantitative trait loci (QTL) analysis has also been used to provide initial 
genomic areas which may contain genes associated wih baseline locomotor activity as 
 17 
 
well as locomotor sensitivity to a D2-like agonist (quinpirole, 0.01-0.03mg/Kg) (30).  In 
this study, a significant QTL was found on Chromosome 9, while suggestive QTL’s on 
Chr 15, 13, and 5 (30).  The authors suggested that the dopamine system was involved 
in the regulation of baseline locomotion because sev ral dopamine related genes 
including Drd2, Drd3, and DAT fell within the QTL identified in this research (30).  
 Pharmacological studies also suggest the D3 receptors are important in the 
regulation of locomotor behavior in animals, specifically acting in an inhibitory manner 
in regard to locomotion in response to locomotor-stimulating amphetamine treatment 
(47, 222).  McNamara and colleagues (164) investigated the role of the D3 receptor in 
locomotion in two distinct inbred strains of mice.  They found that compared to DBA/2J 
mice, C57BL/6J mice had less inhibitory response to several locomotor-stimulating 
effects such as novelty, amphetamine treatments, and a D1 agonist (SKF38393, 5-
20mg/Kg).  In addition, C57BL/6J mice had less D3 receptor expression and/or binding 
density in several areas of the brain including the substantia nigra/ventral striatum, but 
greater expression in the hippocampus than the DBA/2J mice (164).  These data suggest 
that another potential factor in the observed variation in locomotor response to 
pharmacological stimulants between strains of mice is the difference in locomotor 
inhibitory characteristics of dopamine receptor signaling.   
 It is apparent from studies involving D1-like and D2-like agonists and 
antagonists that the dopamine receptors play a role in locomotor behavior in mice or 
rats; however, there is not a consensus on the exact mechanism through which the 
dopamine system (including the dopamine receptors and tr nsporter) is able to mediate 
the locomotor effects of these different dopaminergic acting drugs.  This lack of 
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consensus is probably due to two reasons: First, it i  hard to discern an exact definition 
of “locomotion” and methodologies for measuring such a complex behavior are hard to 
control and differ between studies; and second, the dopamine system is a complex 
system, and as noted earlier, receptor signaling may interact, as well as have different 
outcomes depending on the area of brain and type of n uron involved in the signaling.  
Thus, although it is clear that the dopamine system plays a key role in regulation of 
drug induced locomotion, the question still remains as to the mechanisms by which 
locomotion is altered and whether this system plays a role in regulating general physical 
activity patterns. 
 More recently, the development of knock-out and transgenic animals has 
enabled researchers to further study the role of specific dopaminergic genes (and thus, 
receptors) in regulating locomotion behaviors (300).  Mice lacking the D1a receptor 
have been shown to have normal locomotion and coordination, but reduced exploratory 
activity (57).  In another study, Xu et al. (295) showed D1a receptor knock-out mice 
actually had increased locomotor activity as measured by photo beam breaks and 
suggest D1 receptors are critical in the striatum for normal locomotor behavior.  D3 
receptor knock-out mice also show increased exploratory locomotor behavior 
(“hyperactivity”), suggesting this receptor has an inhibitory role in the regulation of 
exploratory locomotion (2).  Antisense treatment targeting the D3 receptor (effectively 
turning this gene off temporarily) in rats induced an increase in spontaneous locomotion 
again suggesting an inhibitory role of this receptor in locomotor behavior (62).  D1/D3 
receptor knock-out mice also provide insight into the interactions the dopamine 
receptors may have in order to mediate locomotor behavior.  D1/D3 receptor knock-out 
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mice have normal “baseline locomotion” but significantly reduced exploratory 
locomotion suggesting the D1 and D3 receptors work synergistically to manifest certain 
locomotor phenotypes (120). 
 D2 receptor knock-out mice typically exhibit reduced locomotor behaviors 
among other postural and growth abnormalities (11).  Several studies have shown that 
mice lacking D2 or D4 receptors also show reduced spontaneous locomotor activity (11, 
122, 211); however, these same mice showed variable responses to locomotor inducing 
drug stimulants such as the D1 agonist SKF38393,(122) the D2 agonist quinpirole, 
(122) ethanol, cocaine, and methamphetamine (211), making the exact mechanisms 
involved difficult to ascertain.   
 In addition to single receptor knock-out animals, Dracheva et al. (2001) studied 
locomotion in D1 receptor overexpressing animals, and found that mice that 
overexpressed D1 significantly reduced locomotion in response to a D1 agonist, but 
control mice increased locomotion in response to the same drug (56).  The results of this 
study suggest that D1 receptor signaling may have inhibitory effects on certain types of 
locomotor activity, as do the D3 receptors as mentioned previously.  A study of D1 
overexpressing/D2 receptor deficient mice showed that decreased locomotion in hybrid 
D1 overexpressing/D2 receptor deficient mice appeared to be mediated by D1 receptors, 
and that reduced locomotion in the hybrid animals wa  not dependent on D1/D2 
interactions (55).  In this case, D1/D2 interaction was not necessary for dopaminergic 
regulation of locomotion.   
 DAT knock-out and knock-down mice have also been studied which show 
increased locomotor activity, and this hyperactivity can be reduced by psychostimulant 
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pharmacologic agents (83, 302).  These data suggest DAT, and thus, overall presence of 
dopamine, and dopamine signaling are as important to locomotor behavior regulation as 
the dopamine receptors themselves. 
 From the transgenic and knock-out data available, it appears that D1 and D3 
receptors may play an important inhibitory role in certain types of locomotor behavior, 
while D2-like receptors appear to facilitate certain spects of locomotion.  Because the 
dopaminergic system is complex and involved in many spects of development, it is 
hard to discern if these conclusions are due to deletion of the targeted gene or whether 
the resultant effects on behavior are a result of oher compensatory changes in the 
dopamine system.  Thus, studies of dopamine receptor knock-out mice and locomotor 
behavior must be interpreted with care, and while knoc -out models can be useful in 
studying gene function, this model may not be the best model for investigating 
dopaminergic regulation of physical activity.  Temporary gene silencing methods such 
as RNAi technology could potentially be used in the future to study the effects of 
knock-down of dopamine genes on physical activity.  Please refer to Appendix A for 
more information on gene silencing. 
Wheel Running Studies 
 In addition to the general locomotor studies, evidence for involvement of the 
dopamine system with physical activity levels can also be found in wheel running 
studies conducted in animals.  A strong case has been made that wheel running in 
animals is an appropriate model of voluntary physical activity in humans (61, 234).  
Thus, as opposed to the drug induced locomotion studies, wheel running studies may 
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give more accurate insights into the involvement of the dopamine system in general 
physical activity levels in humans. 
   Inbred mice strain differences in both dopaminergic anatomy and wheel running 
may prove useful in elucidating how genetic differenc s in dopaminergic signaling may 
differentially regulate physical activity in inbred mice.  Lightfoot and colleagues 
screened 13 strains of mice for distance, duration, and speed on a running wheel, and 
found significant differences between strains in all running wheel indices, indicating a 
significant genetic component to regulation of physical activity behavior (149). 
Additionally, strain differences in dopamine anatomy and function have also been 
shown by various authors (13, 164, 168, 177, 227, 232 52).  For example, Fink and 
Reis, 1981, showed that BALB/cJ mice have more dopamine activity in both the 
nigrostriatal, and mesolimbic pathways in the brain compared to CBA/J mice (70).  
Combining the knowledge that CBA/J and Balb/cJ mice diff r in dopaminergic 
anatomy in the mid-brain (70), as well as differ in wheel running indices (149), it is 
reasonable to suggest that genetic differences in the dopamine system between inbred 
strains of mice may translate into behavioral differences, including voluntary wheel 
running.  Similarly, work done recently in our lab (126, 127) suggests expression 
differences of D1-like receptors as well and tyrosine hydroxylase between differentially 
active inbred strains may be important in mediating behavior differences in running 
wheel activity in differentially active inbred mice.   
 Supporting the hypothesis that genetic differences in the dopamine system may 
mediate behavioral differences in animal models is work done using selective breeding.  
Bronikowski and colleagues (2004) investigated gene expression changes in the 
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hippocampus region of the brain and found that mice sel ctively bred for high wheel 
running had a 20% increase in D2 and D4 receptor expression (D1-like receptors were 
not analyzed in this study) compared to control line mice (29).  Also, Rhodes et al. 
(2003) investigated patterns of brain activity in mice selected for high wheel running, 
and found that certain areas of the brain exhibited increased activity (as measured by 
Fos expression) in selected animals compared to the control animals (200).  Several of 
the regions identified in this research, including the nucleus accumbens, striatum, 
prefrontal cortex, and lateral hypothalamus are regions associated with high 
dopaminergic activity.  Another study by Waters et al. (2008) in rats selectively bred for 
high aerobic capacity showed that the high capacity rats exhibited increased wheel 
running activity compared to controls while also exhibiting increased dopaminergic 
activity in the striatum area of the brain compared to low aerobic capacity rats (277).  
The authors suggested that artificial selection mayhave acted upon the dopamine 
system because the dopamine system is involved in motivation and that wheel running 
activity is a motivated behavior (277).  Thus, combining the knowledge from genetic 
studies of dopamine and wheel running in both inbred and selectively bred mice it is 
warranted to investigate further the connection betwe n the dopamine system and wheel 
running in animals.     
 Further elucidation of the role of the dopamine system in wheel running comes 
from investigations of the effects of pharmacological nterventions (specifically 
psychoactive drugs) on wheel running in mice.  The sel ctively bred mice mentioned 
above (see Garland et al. 2006 for a complete description of these selectively bred mice) 
(84) responded differently than controls to several dopaminergic acting drugs including 
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D1-like and D2-like agonists and antagonists, suggesting a dopaminergic involvement 
in regulation of wheel running in these selected anim ls (199, 201).  Specifically, 
selected animals significantly reduced their wheel running by decreasing their speed as 
compared to control animals in response to cocaine nd GBR 12909 (201).  Both of 
these drugs act by inhibiting DAT which effectively increases the amount of dopamine 
in the synapse.  In another study, Rhodes and colleagues (2003) showed that a DAT 
inhibitor (Ritalin, 15mg/Kg and 30mg/Kg) decreased wheel running in selected animals, 
but increased wheel running in control animals.  A non-selective dopamine agonist 
(apomorphine, 0.25mg/Kg and 0.5mg/Kg) decreased wheel running more in control 
animals compared to selected animals at higher doses.  Additionally, a selective D1-like 
antagonist (SCH-23390, 0.025-0.1mg/Kg) decreased wheel running in the control 
animals more than selected animals, while a selective D2-like antagonist (raclopride, 
0.5-2.0mg/Kg) had similar effects on both selected an control animals (199).  These 
results suggested that D1-like receptors and DAT were involved in mediating the 
differences seen in wheel running between the selected animals compared to controls, 
but not the D2-like receptors.  Earlier studies by Schumacher and colleagues (1994) 
using mice classified as high active, or low active based on performance in a running 
wheel test, also showed differential locomotor responses to dopamine agonists such as 
apomorphine, bromocriptine, and amphetamine between the high active and low active 
mice.  Specifically, bromocriptine and amphetamine stimulated physical activity more 
in the low active mice compared to the high active mice, suggesting a decreased 
functioning of the mesolimbic dopamine system in the high active mice (226).  A study 
conducted in 2004 by Leng and colleagues showed that C57Bl/6 mice, after pre-
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treatment with MPTP (a dopaminergic neurotoxin), exhibited significantly reduced 
wheel running after treatment with a tyrosine hydroxylase inhibitor which effectively 
reduced dopamine synthesis, highlighting the importance of dopamine itself, in addition 
to individual dopamine receptors, in the regulation of physical activity in the form of 
wheel running in mice (140).  Additionally, it has been recently shown that C57L/J 
mice (high active) (149) significantly reduce wheel running in response to a D1-like 
agonist, but do not significantly change wheel running behavior in response to a D1-like 
antagonist, dopamine re-uptake inhibitor, or a tyrosine hydroxylase inhibitor (127).  
C3H/HeJ mice (low active) (149) did not respond to the D1-like agonist or antagonist, 
but did significantly increase wheel running in response to a dopamine re-uptake 
inhibitor (127).  Genetic differences in the dopamine system between C57L/J mice and 
C3H/HeJ mice could explain the differential response to dopaminergic acting drugs.  
Specifically, it appears that signaling through D1-like receptors is important in 
mediating the high activity observed in C57L/J mice, while dopamine half-life and 
presence in the synapse is more important in mediating wheel running behavior in low 
active C3H/HeJ mice. 
 As is apparent from the above literature, a preponderance of evidence suggests 
that the dopamine system is involved in the regulation of wheel running behavior and 
general locomotion in mice.  From a genetic aspect, studies suggest inbred strains of 
mice, as well as mice selectively bred for high amounts of wheel running differ not only 
in amount of physical activity performed, but also in dopaminergic anatomy, and thus 
function, in the mid-brain.  Similarly, pharmacological studies provide insight into the 
possible role of the dopamine system in regulation of wheel running behavior.  
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However, it is still unclear whether the dopamine system is acting in an independent 
fashion to control physical activity or if there are possible dependent changes in the 
dopamine system due to physical activity which is in-turn mediating activity behavior.   
Going Further:  Linking the Dopamine System and Regulation of Physical Activity in 
 Humans 
 
 It is known that exercise acts as an independent agent to cause changes in 
various neurotransmitter systems, specifically the dopamine system, noradrenergic 
systems, and the serotonergic system (165).  For example, exercise increases the 
amount of dopamine released and metabolized in certain areas of the brain (276). In this 
respect, changes in the dopamine system act in a depen nt fashion in response to 
exercise.  However, this dependent change in the dopamine system is usually 
accompanied by a positive reinforcing response in which the dopamine system in-turn 
acts in an independent fashion causing changes in behavior to seek rewarding and/or 
pleasurable responses (290).  Even though we can postulate that seeking rewarding 
and/or pleasurable responses in humans leads to increased physical activity, evidence is 
still lacking as to whether the dopamine system is actually working in an independent 
role in influencing voluntary physical activity.  In other words, it is known that exercise 
causes changes in the dopaminergic system, but does the dopaminergic system itself 
also act as an independent variable to regulate overall physical activity levels?   It has 
been shown that dopamine neurons in the striatum are primarily responsible for changes 
in motor activity (218), while dopaminergic function in the nucleus accumbens is 
involved in anticipatory behavior (anticipation of a reward or “motivation”) (25, 186, 
216).  Dopamine depletion studies in the nucleus accumbens of rodents showed a 
decreased motor activity response to certain drugs (41), and dopamine depleted animals 
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showed lack of motivation for more effortful tasks (40, 215).  Thus, there is overlap 
between the motivational aspects and motor control aspects of brain neurology (212), 
with the dopamine system mediating both portions.  This multifaceted role of the 
dopamine system provides reason to investigate the relationship between dopaminergic 
activity in the brain and amount of voluntary physically activity that the organism 
undertakes. 
 The fact that exercise is often used as a treatment in depression also illustrates 
the dependent role of the dopamine system in response to physical activity.  It has been 
shown that exercise alleviates symptoms of depression, most likely mediated through 
changes in the central nervous system in the brain (58).  Along this same line of 
thought, the benefits of physical activity on the brain seem to be primarily mediated 
through catecholamine systems.  Exercise and/or physical activity is known to increase 
neurotransmitter production and metabolism (52, 53, 1 7), which are thought to lead to 
changes at the molecular and cellular level that improve neuronal plasticity (73, 165), 
cognitive functioning (237), learning (289), and overall mood (53), all aspects that 
protect brain function.  Mice that perform voluntary physical activity in the form of 
wheel running produce more brain-derived neurotrophic factor, causing an increase in 
synaptogenesis and neurogenesis, neuron survival, and increased learning capacity, all 
leading to possible protection from cognitive decline (39).  Similarly, it has been shown 
that moderate physical activity decreases the risk of Parkinson’s Disease (155, 258), as 
well as helps alleviate and slow the progression of symptoms of the disease (72, 133).   
 Training studies have also shed light on the dependent changes in the dopamine 
system in response to exercise in the form of training.  Rats who underwent endurance 
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training showed increased D2 receptor binding over th  lifespan compared to control 
animals, suggesting that endurance training provided some protection from age related 
loss of D2 receptor functioning (158).  Likewise, rats exposed to treadmill running had 
increased Fos expression in the striatum area of the brain mediated through D1 
receptors (154).  Similarly human exercise training studies show dependent changes in 
neurotransmitter systems, including the dopamine system (19, 27, 37, 104, 128, 183), in 
response to exercise, and these cause and effect changes are likely due to dopamine’s 
involvement in control of sympathetic nervous activity (161).  In these particular studies 
dopamine was treated as the dependent variable in response to exercise, or training.  
However, some research suggests that not only is dopaminergic functioning altered in 
response to exercise, but perhaps the dopaminergic system also acts in an independent 
fashion on physical activity levels.  For example, a study in humans using PET imaging 
showed no changes in dopamine D2 receptor availability in the caudate putamen after 
treadmill running (submax); however, the subjects used in this study were already 
persons with a history of regular exercise (274).  It is plausible to assume that one 
reason no difference was seen from baseline, is that dopamine release in the striatum 
may not have been the true dependent variable in this methodology.  It would be 
interesting to compare PET imaging of regular exercis s to non-exercisers in the case 
that dopamine signaling may work in an independent manner in relation to physical 
activity, and even training in some circumstances.  Further support for an independent 
role of dopamine and physical activity comes from genetic studies linking single 
nucleotide polymorphisms in the DRD4 (99), and DRD2 genes (235), with physical 
activity levels in humans.  Similarly, aging studies suggest an independent mechanism 
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of action for the dopamine system and regulation of physical activity levels.  It is known 
that a decline in physical activity over the lifespan is most likely due in part to a decline 
in the functioning of the dopaminergic system (207).  However, as mentioned, studies 
show that physical activity in the form of exercise can slow the rate of decline in 
functioning of the dopamine system, and increase quality of life.  Thus, the benefits of 
physical activity on central nervous system functioning suggests that the dopamine 
system can have both a dependent and independent mechanism of action in regulation 
of physical activity levels. 
 It is clear that the dopaminergic system is affected by physical activity, and it is 
highly likely that the amount of voluntary physical activity is regulated at least in part 
by the dopamine system.  The mechanisms behind this correlation are yet to be fully 
understood. 
Dopamine, Reward, and possible implications for Physical Activity Regulation 
 A full neurobiological discussion of the role of the dopamine system in 
reinforcement and reward is outside the scope of this review; however, a brief 
discussion of the reward pathways is necessary to relate the proposed relationship of the 
dopamine system to regulation of physical activity.  In the past several decades it has 
become increasingly clear from studies in drug addiction that dopaminergic signaling 
mediates behavioral responses to rewarding stimuli (225).  Rewards, in and of 
themselves, provide three basic functions including eliciting a behavior, providing 
reinforcement (or positive feedback so as to increase the frequency or intensity of the 
behavior), and provision of some type of pleasurable feeling or response (225).  With 
the context of these three basic functions, it is clear that drugs of abuse are “addictive” 
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because they provide all three functions of a “reward”.  It is generally accepted that the 
dopamine system is implicated in reward and reinforcing mechanisms as evidenced by 
the results of psychostimulant administration (49, 290).  Specifically, the administration 
of psychostimulant drugs increases dopamine release and signaling in the mesolimbic 
areas of the brain, while withdrawal of these drugs causes a decrease in dopamine 
signaling in these areas and this response appears to be mediated by both D1 and D2 
receptors (77, 131).  Studies suggest that D2 receptors are responsible for mediating the 
self-reinforcing effect of drugs, while the D1 receptors act in a permissive fashion to 
facilitate the response.  Both D1 and D2 agonists elicit a reinforcing response and have 
effects similar to cocaine administration; however, the D1-like receptors and D2-like 
receptors mediate different aspects of this self-reinforcing response (230).  Cocaine self-
administration studies suggest the D2 receptors are responsible for mediating further 
motivation to seek cocaine, while the D1 receptors may mediate a reduced drive to seek 
further cocaine reinforcement (230).   
 More recent evidence has led researchers to suggest that the dopamine system is 
specifically involved in the motivational aspect of reward for natural stimuli such as 
food.  Dopamine depletion and dopamine antagonist studies in the nucleus accumbens 
of animals show that appetite for food is not reduced under these conditions; however, 
the motivation to engage in effortful tasks for food is significantly reduced (214).  Thus, 
the dopamine system appears to regulate certain aspects of the “wanting” instead of the 
“liking” of natural rewards (23).  Drugs of abuse ar  typically thought of as artificial 
rewards, while actions such as sexual behavior, food, and/or exercise can be termed 
“natural rewards.”  Traditionally, it has been assumed that drugs of abuse initiate the 
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natural reward system in the brain, mainly the dopamine system, and thus act in a 
similar fashion as natural rewards.  This theory, which is based on the notion that the 
dopaminergic system mediates the reinforcing properties of natural rewarding stimuli, 
has been known as the “General Anhedonia Model” (217).  As stated, this theory may 
not be the entire picture as it appears that the dopamine system may mediate the 
motivation for natural rewards, and not necessarily the reinforcement mechanism at 
least in the case of food rewards.  Thus, the dopamine system and its role in mediating 
reward is complex, and the exact mechanisms through which the dopamine system 
mediates reward signaling to natural rewards such as physical activity is not known.  
However, it is increasingly clear from genetic studies involving locomotion and wheel 
running, as well as evidence from reward signaling in response to naturally rewarding 
behavior that the dopamine system plays a role in the regulation of physical activity in 
regard to mediating the natural rewarding properties of this behavior.    
Proposed Model for Dopaminergic Regulation of Physical Activity 
 As already outlined in this review, it is well known that exercise induces 
changes in neurotransmitter systems as well as endorphin release and signaling.  These 
changes typically depend on intensity and duration of exercise.  To date, most studies 
investigating changes in neurotransmitters due to exercise treat the neurotransmitter 
changes as the dependent variable.  Studies involvig motor movement and/or 
locomotion, wheel running, and addiction however, provide evidence for a regulatory 
role of the dopaminergic system on voluntary physical activity.  Furthermore, it is 
warranted to propose a dual role for the dopamine system in the genetic and biological 
regulation of physical activity.  First, it appears that physical activity in the form of 
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exercise itself and/or training produces beneficial hanges in the dopamine system 
including increased dopamine signaling as well as increased BDNF levels in the brain.  
In this role, dopamine signaling is acting in a dependent fashion to mediate central 
changes in response to physical activity.  Second, it is also apparent from the growing 
amount of literature on the role of the dopamine system in motivation for natural 
rewards, that the dopamine system creates a positively reinforcing condition in which 
the dopamine system acts in an independent fashion controlling the “wanting” and/or 
motivation for natural rewarding stimuli such as physical activity.  Thus, it is proposed 
that dopaminergic signaling acts in both a dependent and independent fashion in the 
regulation of physical activity (proposed schematic outlined in Figure 3). 
 Going back to the equation mentioned in the first part of this review, any 
phenotype is affected by both genetic and environmental components, as well as 
biological interactions:  
Phenotype = environment + genetics/biological factor + environment/genetic interaction). 
Genetic studies involving dopamine and locomotion outlined in this review provide a 
solid basis for genetic differences in the dopamine system mediating behavioral 
differences in regard to physical activity in animals.  Not covered in this review, but 
still very important, are the biological interactions that may also be playing a role in 
dopaminergic regulation of physical activity.  The dopamine system does not act in 
isolation, and is affected by interaction with other n urotransmitter systems such as 
serotonin.  Other biological and/or environmental factors such as hormonal influences 
may also play an important role in this regulation.  A proposed model for this regulation 
is outlined in Figure 3.  The dopamine system appears to be a central component 
determining the phenotype of physical activity in that dopaminergic signaling is 
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determined in part by genetics, is also influenced by the environment, and can interact 
with the environment and other biological components.  Thus, the dopamine system 
appears to act in a dual role – both dependently and independently to regulate levels of 
physical activity performed by a given animal.  As a result, it is important to take a 
multifaceted approach for future research to seek out the underlying mechanisms of this 
genetic/biological regulation of physical activity n order to improve human health and 
prevent disease. 
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Figure 1:  Model of brain dopaminergic tracts. 
 
 
Figure 1:  This figure illustrates the known dopaminergic neuronal tracts.  The nigro-
striatal tract consists of dopaminergic neurons originating from the substantia nigra, and 
projecting into the striatum.  This tract is thought to be involved in control of motor 
movement.  The mesolimbic tract is made of dopaminerg c neurons projecting from the 
ventral tegmental area (VTA) into the nucleus accumbens, frontal cortex, and 
hippocampus.  This area is thought to be involved in motivation, reward, and learning.  
Thus, the striatum and nucleus accumbens may play an important role in regulating the 
motivation for physical activity.  Dashed arrows indicate specific brain regions, while 
blunt ended solid line arrows indicate dopaminergic neuronal tracts. 
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Figure 2:  Representative dopaminergic synapse 
 
 
 
Figure 2:  The above illustration is a representative dopaminergic synapse.  The 
signaling pathways in the postsynaptic neuron are only representative of D1-like 
receptor signaling (which increases cAMP).  D2-like receptors are known to have 
opposite affects on cAMP activity, and thus slightly different downstream signaling 
cascades.  Dopaminergic signaling effects on ion channels and membrane permeability 
are not shown however, may be important in the regulation of behavior such as physical 
activity.  For a full review of the signaling cascades proposed to be involved in D1-like 
and D2-like receptor signaling please refer to Neve t al. 2004 (176).  Abbreviations:  
AC5 – adenylate cyclase 5;  ATP – adenylyl tri-phosphate; CREB – cyclic AMP 
response element binding protein; DARPP-32 – dopamine and cyclic AMP-regulated 
phosphoprotein (thought to be important in positive feedback signaling); D1 – 
dopamine receptor 1; MAPK – mitogen-activated protein kinase; PKA – protein kinase 
A; PKC – protein kinase C; PLC – phospholipase C. 
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Figure 3:  Proposed Schematic of the role of dopamine system in the central regulation 
      of physical activity 
 
 
 
Figure 3:  It is proposed that the dopamine system can act in both an independent and 
dependent manner in regard to regulation of physical a tivity.  Both genetic factors, and 
biological factors that interact with the genetic machinery, are important in second 
messenger signaling, and downstream gene expression changes to dopaminergic 
neuronal signaling.  Likewise, it is also possible that physical activity (i.e. intensity and 
duration of exercise) can cause changes in neuronal signaling as well, possibly 
mediating a reinforcing behavioral mechanism.  Proposed differential effects on 
physical activity of D1-like vs. D2-like receptor expression, DAT function, and 
Tyrosine Hydroxylase function are included.  “?” indicates unknown signaling 
pathways. 
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Table 1:  Summary of dopaminergic findings in selectively bred mice for high WR 
Area of Brain Methods Finding Conclusions Reference 
Hipocampus Gene Array 
24% ↑ D4  
receptors          
19% ↑ D2 
receptors 
small changes in gene 
expression in the brain 
can cause large 
phenotypic changes.  D1 
receptors were not 
analyzed. 
Bronikowski et 
al., 2004 
Lateral 
Hypothalamus, 
Medial Frontal 
Cortex, 
Striatum 
Fos expression 
in selected mice 
blocked from 
wheel 
↑ Fos expression  
Different brain regions in 
control of intensity of 
running vs. motivation 
for running 
Rhodes et al., 
2003 
N/A 
Agonists, 
Antagonists,  re-
uptake inhibitor 
Differential 
responses in WR 
in selected mice 
vs. controls 
D1-like receptors likely 
involved in mediating 
high WR in selected mice 
Rhodes and 
Garland, 2003 
Table 1:  Evidence from studies in selectively bred mice for high wheel running suggest 
the central regulation of physical activity likely involves the dopamine system. 
 
 
Table 2:  The dopamine system and locomotion in disease states 
Disease 
Parkinson's 
Disease ADHD Anorexia Addiction 
Possible 
Mechanism 
loss of DA 
neurons 
DRD4/DRD5 
and DAT 
D2/D3?  Altered 
signaling 
D1/D2, DAT, 
altered 
signaling 
locomotor 
outcome 
lack of motor 
control 
Hyperactive 
Phenotype 
↑ drive for 
activity (other 
OCD 
tendencies) 
mediates 
motivation for 
pleasure/reward 
seeking 
 
Table 2:  Dopamine signaling plays a prominent rolein locomotor dysfunction in 
several disease states.  Possible mechanisms are lited based on the described literature
 
 
 
 
CHAPTER 2: 
 REPEATABILITY OF EXERCISE BEHAVIORS IN MICE 
 
 
Abstract: 
 Purpose:  Measurements of exercise behaviors in rodents such as maximal 
treadmill endurance and physical activity are often used in the literature; however, 
minimal data are available regarding the repeatabili y of measurements used these 
exercise behaviors.  This study assessed the repeatability of a commonly used maximal 
exercise endurance treadmill test as well as voluntary physical activity measured by 
wheel running in mice.  Methods: Repeatability of treadmill tests were analyzed for 
both inbred and outbred mice in addition to a 10 week repeatability analysis using 
Balb/cJ mice (n=20).  Voluntary daily physical activity was assessed by; distance, 
duration, and speed of wheel running (47).  Physical a tivity measurements on days 5 
and 6 of WR in a large cohort (n=739) of both inbred and outbred mice were compared.  
Results:  No significant differences (p>0.05) in exercise endurance were found between 
different cohorts of Balb/cJ and DBA/2J mice; however, significant differences were 
seen within BaD2F2 animals (p<0.001).  Weekly endurance testing over 10 weeks in 
Balb/cJ mice showed significant differences among weeks for female mice (p = 0.04), 
no significant differences among weeks in male mice (p = 0.33), and no significant 
correlations between paired endurance measures within each mouse.  Within mouse 
comparisons of exercise endurance tests showed large average percentage differences 
between tests in all mice (404±463%, mean±SD). No significant differences were found 
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for WR measurements within mouse between days (p=0.99).  High correlations between 
days within mouse for WR was found (r=0.74-0.85).  Conclusions:  High intra-mouse 
variability between repeated endurance tests suggests that treadmill testing in an 
enclosed chamber with shock grid for motivation to run in mice is not repeatable.  
Conversely, high correlations and low percent differences between consecutive 
measurements of WR suggest that measurements of voluntary activity are repeatable 
and stable within individual mice. 
Key Words:  running wheel, endurance, treadmill, physical activity 
Introduction: 
 Most measurements of exercise behavior in humans (e.g. exercise endurance, 
VO2max, activity level) have been shown to be repeatable within subject (24, 162, 282).  
With this precedence, measurements of exercise endura ce and daily physical activity 
in rodents are often used to investigate regulating mechanisms associated with exercise 
that are difficult to measure in humans (142, 149, 151).  Given the high test-retest 
repeatability for human exercise behavior measurement, it is natural to assume that 
endurance tests in rodents would also be repeatable and stable.  However, repeatability 
of exercise measurements in rodents must be established to ensure valid physiological 
conclusions from such studies. 
 Exercise behavior testing in rodents usually consists of either the determination 
of exercise endurance/capacity and/or voluntary daily activity.  Forced exercise capacity 
tests in rodents generally use small treadmills encapsulated by a chamber to assess 
maximal exercise endurance and/or VO2max (129, 141, 150, 255, 279).  These treadmill 
protocols typically use a variety of stimuli (e.g. shock grid, tail tapping, or high pressure 
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bursts of air) to motivate the animal to run.  Treadmill testing for assessment of 
endurance/aerobic capacity in rodents has been generally preferred to swimming tests 
since rodents do not display consistent swimming behaviors (e.g. animals will bob, 
float, and/or dive) and these behaviors skew any data investigating aerobic capacity 
(132).  Several variations of exercise treadmill protocols have been used with rodents 
(15, 129, 142, 150, 151, 195, 255, 279);  however, in the current literature, limited 
studies report a measure of repeatability of forced tr admill testing within animal (20, 
79, 195).  These studies report within animal repeatability of VO2max measurements, 
using enclosed treadmill protocols ranging from r=0.42 to 0.97 (20, 79, 195).  In spite of 
the wide use of exercise endurance treadmill testing in rodents, no repeatability 
measures of maximal running time using enclosed chambers without VO2max 
measurement have been reported.  Koch and colleagues used a protocol consisting of 
five consecutive endurance tests on consecutive days (129) and have reported that “120 
runs in 24 female rats were found not to be different from a normal distribution as 
assessed by the Kolmogorov-Smirnov test”.  Unfortuna ely, it was not noted whether 
the five tests differed significantly from each other, and it is not clear whether this is a 
good indicator of repeatability.  Thus, although some papers present some form of 
repeatability of VO2max measurements in rodents, no studies have systematically 
analyzed the within subject repeatability of forced exercise treadmill tests in rodents. 
 The other most common measurement of exercise behavior in rodents involves 
the determination of daily voluntary activity levels using wheel running (69, 149, 152, 
253, 257, 262, 298).  Much like exercise endurance, day-to-day wheel running within 
strains of rodents has been assumed to be repeatabl; however, little data is published 
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regarding this assumption.  Friedman and colleagues (79) evaluated several locomotor 
behaviors including wheel running in 35 random bred male ICR mice and reported a r-
value=0.852 (with deletion of one outlier) between days 6 and 7 of wheel running.  
Additionally, Swallow et al. (255) tested 577 male nd female mice selectively bred for 
high-wheel running activity and reported a r-value=0.787 for females, and a r-
value=0.868 for males for repeatability of wheel running between days 5 and 6 of data 
collection. 
 Given the relative paucity of the data regarding the repeatability of rodent 
exercise behaviors in the literature, the goal of this study was to examine the 
repeatability of commonly used forced exercise treadmill tests and daily voluntary 
physical activity measurements in several cohorts of inbred and outbred mice. 
Methods: 
Overview 
 A variety of different mouse cohorts were used in the completion of this study.  
Archived, unpublished data from several previous stdies (149-152) as well as data 
collected specifically for this project are reported in this paper.  All procedures were 
reviewed and approved by the University of North Carolina Charlotte Institutional 
Animal Care and Use Committee, conformed to the anim l care policies of the U.S. 
Department of Agriculture (USDA), and conformed to the Resource Book for the 
Design of Animal Exercise Protocols (132).  All animals were housed in the University 
Vivarium with 12 hour light/dark cycles, were provided standard rodent chow (Harlan 
Teklad) and water ad libitum, and were weighed weekly.  Mice used in maximal 
exercise treadmill tests were group housed with 4 mice per cage and identified using ear 
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punches.  Mice used during wheel running experiments were single housed in rat size 
cages and identified using a unique mouse number as well all other identifying 
information on cage cards. 
Animals Used 
 Exercise Endurance repeatability:  The first question we sought to answer was 
whether exercise endurance was similar within inbred strain between different mouse 
cohorts separated in time.  This question directly addressed whether exercise endurance 
within a particular strain of mouse was stable over time and was determined by 
comparing exercise endurance from two cohorts of Balb/cJ and DBA/2J inbred mice 
tested in the same manner in 1999 (150) and in 2005(unpublished data).  With both 
cohorts, we used an open treadmill, which allowed manual stimulation of the animal 
(tapping the tail) in conjunction with a shock grid to encourage running.  Otherwise, the 
procedures used were the same as that addressed below.  The strains tested in 1999 
consisted of eight female Balb/cJ (weight = 19.0±1.2g) and seven female DBA/2J mice 
(weight = 16.9±1.4g), while the 2005 cohort consisted of 10 female Balb/cJ (weight = 
20.6±0.8g) and 10 female DBA/2J mice (weight = 20.4±1 6g). 
 To determine repeatability of exercise endurance i outbred mice at two distinct 
time points, we compared exercise endurance from 80 BaD2F2 outbred mice that were 
tested using a sealed metabolic chamber that used a hock grid as the sole means to 
motivate exercise.  These 80 mice were chosen from a cohort of 300 F2 mice because 
they exhibited either high (n=40) or low (n=40) endurance during a maximal endurance 
test conducted using methods outlined below and previously published (150).  These 
mice were developed by reciprocally crossing high endurance Balb/cJ and low 
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endurance DBA/2J inbred strains (150), and exercise endurance of the BaD2F2 mice 
was measured at 86.3±7.2 days (weight = 23.1±3.1g) and 140.1±5.3 days of age (weight 
= 24.9±2.7g). 
 Finally, to investigate the actual within mouse repeatability of exercise 
endurance across shorter time spans, but without intervening exercise training, 20 
Balb/cJ mice (10 female, 10 male), were exercise endurance tested using the sealed 
metabolic treadmill approximately every seven days fter two orientations to the 
treadmill (see below).  Balb/cJ mice were chosen for this protocol because previous 
studies have shown this strain to perform well on forced treadmill tests (150).  The 
males were tested every seven days starting at age 41.5±0.5 days.  To eliminate possible 
sex hormone effects on exercise endurance, the female ice were tested during the 
diestrous phase of the estrous cycle which was determin d by the presence of cornified 
epithelial cells in a vaginal smear (6).  This testing began when the females were 
44.6±0.5 days of age and given the normal length of t e estrous cycle (≈4-5 days, with 
diestrous lasting 2-2.5 days), endurance treadmill testing was accomplished 
approximately once every seven days. 
 Physical Activity repeatability:  We also determined if measurement of 
voluntary physical activity using a running wheel were repeatable.  The data used to 
determine the repeatability of physical activity were taken from a large dataset using a 
base cohort of 739 mice from 22 inbred strains (n= 367; 129s1/SvImJ, A/J, AKR/J, 
Balb/cJ, C3H/HeJ, C3Heb/FeJ, C57BL/10J, C57BL/6J, C57BLKS/J, C57L/J, CAST/Ei, 
CBA/J, CE/J, DBA/2J, LP/J, MRL/MpJ, NZB/BinJ, PL/J, SM/J, SPRET/Ei, SWR/J, 
WSB/Ei) and from 2 outbred strains developed in our laboratory (n=372, C3C5F1, 
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C3C5F2).   Within this large cohort, there were 324 females and 415 males.  Given that 
the highest activity levels for mice generally occur between 9 and 12 weeks of age 
(256), we attempted, where possible, to draw data for the day 5/day 6 repeatability 
comparison when the mice were 68-69 days of age (i.e. 9 weeks + 5 days).  Thus, the 
average age of the mice for the day 5-6 comparison was 69.7±7.4 days.  In 34 cases, 
data for the repeatability comparison was shifted from day 5-6 to day 4-5 or to day 6-7 
because of equipment sensor failure on either day 5 or 6 of wheel running exposure.  It 
is common in wheel running literature to report repeatability based on day 5 and 6 of 
wheel running exposure (254). 
Forced Maximal Endurance Testing 
 Similar methods were used to determine exercise endura ce for all mice (150, 
151) with the exception of the use of an open treadmill or a sealed, metabolic treadmill 
(5.08 cm x 38 cm; Columbus Instruments, Columbus, OH).  All mice, regardless of the 
treadmill used, had one or two orientation exposures to the treadmill, each separated by 
at least 48 hours from the other orientation exposure or an exercise endurance test.  In 
all cases, the front eight cm of the treadmill chamber was covered to provide a dark area 
for the mice to run toward.  The first orientation exposure consisted of placing the 
mouse on the treadmill and letting the mouse walk on the treadmill at 16 m/min for 15 
minutes.  A shock grid mounted at the back of the treadmill delivered a 3.0 mA current 
(142, 255) to provide motivation for exercise.  The treadmill endurance protocol 
consisted of a series of stages and has been described previously (150, 151).  Briefly, 
each stage was three minutes long with the initial s age being a period of rest.  At the 
end of the first three minutes, the speed was increased to 16 m/min and then increased 
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by four m/min every three minutes until a maximum speed of 40 m/min.  If the mouse 
was still running at this stage the grade was increased every three minutes by five 
percent.  The test was ended when the mouse sat on the shock grid at the back of the 
treadmill for five seconds, or if the protocol was maxed out at 36 minutes, 40 m/min, 
and 15% grade. 
 To determine if exercise endurance measurement was repeatable over a longer 
period when tested weekly, each Balb/cJ mouse was endurance tested once a week for a 
period of ten weeks.  As noted earlier, female mice were only tested during the 
diestrous phase of the estrous cycle when estrogen lev ls are lowest.  To eliminate 
technician bias, five male and five female mice were randomly assigned to one of two 
technicians and these technicians conducted the endura ce tests on the same ten mice 
each week throughout the study. 
Voluntary Physical Activity Measurement 
 Daily running on the wheel was measured using methods described previously 
(137, 149, 152).  Briefly, mice were housed individually, with a running wheel 
(circumference 450mm; Ware Manufacturing, Phoenix, AZ) mounted in each cage.  
The wheels were equipped with a magnet mounted on the outside surface and the top of 
the cage was equipped with a magnetic sensor (BC500; Sigma Sport, Olney, IL).   Each 
cage computer was calibrated for the wheel circumference allowing for accurate 
measurement of distance (km) and time the animals ran on the wheel (duration = mins).  
Speed of activity (m/min) on both days was calculated by dividing daily distance by 
daily duration of exercise.  The data were collected every 24 hours for 7-21 days and 
data collected on days 5 and 6 were used for repeatability testing.  The wheels were 
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checked manually each day to assure sensor alignment and free-turning of the wheel.  
“Coasting” by the mice, where the mice stopped running while the wheel continued to 
turn with the mouse still on the wheel, was not a concern due to three factors:  1) The 
running wheels used had a metal solid-surface and thus, hey could not grip the wheel to 
coast unlike if the treadmill surface were mesh; 2) the wheels had a diameter that was 
too small for the mouse to run up one side and thencoast as the wheel re-centered from 
the unequal weight on one side of the wheel; and 3) two cross axis bars attaching the 
wheel to the axle prevented the mice from jumping off the wheel while it was still 
turning, thus requiring that the mouse stop the wheel b fore getting off and removing 
any excess wheel spinning.   In addition, anecdotally our research team has not ever 
observed the mice coasting the running wheels we use to measure daily activity. 
Statistical Analysis  
 All analyses were conducted using JMP software (ver. 7.0, SAS Institute, Cary, 
NC) and the alpha value was set a priori at 0.05.  Several analyses were used depending 
upon the questions being examined.  A two way ANOVA (factors = strain and year 
tested) was used to determine the overall stability of exercise endurance between 
different mouse cohorts separated by time.  A two way ANOVA (factors = endurance 
classification and time of measure) with a repeated m asure on one factor (time of 
measure) was used to determine the repeatability of exercise endurance within a cohort 
of F2 mice that were classified on the basis of one exercis  endurance test.  
Determination of the repeatability of exercise endurance every week for 10 weeks 
within the same cohort of animals was accomplished using a two way ANOVA (time of 
measurement and sex) with time of measurement being a repeated factor.  Additionally, 
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due to previous concerns, we conducted pairwise correlations between all 10 weeks of 
endurance testing to determine the association of edurance test results across the 10 
repeated endurance tests.  In all analyses, Tukey’s post-hoc analysis was used where 
significant main effects were observed. 
 A two-way ANOVA (day of measurement and sex) was used to initially 
determine if sex played a role in the repeatability of any of the physical activity 
measurements.  If sex exerted a non-significant main effect, the analysis was repeated 
using paired t-tests with each running wheel index (i. . distance run, duration of 
exercise, and speed of exercise) to determine if activity level measurement was 
repeatable between days 5 and 6 of exposure to a running wheel. 
Results: 
 Different groups of Balb/cJ and DBA/2J mice were endurance tested in 1999 
and 2005.  Results in Figure 1 show that endurance test performance was not different 
between these measurements, within strains of mice (Balb/cJ mice, p=0.55; DBA/2J 
mice, p=0.51) despite being separated by approximately six years.  A large cohort of F2
outbred mice (n=300) were exercise endurance tested at 12 weeks of age and the top 40 
performing animals were classified as “high endurance” and the lowest 40 performing 
animals were classified as “low endurance”.   A second endurance test was conducted 
on these 80 mice within seven weeks of the original test.  Figure 2 shows a comparison 
of the average endurance of the high and low endurace mice between the first and 
second exercise test. In the second test, the high endurance mice exhibited significantly 
less endurance (p<0.001) than on their first test.  Conversely, the low endurance mice 
exhibited significantly higher endurance (p<0.001) than on their first test. 
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 In comparing the 10 weeks of endurance testing among male and female mice, 
no difference in association between max endurance tests were attributed to sex.  Thus, 
all animals were combined, and pairwise correlations were completed for all 20 Balb/cJ 
mice for each week of endurance testing (Table 1).  When compared using repeated 
measures analysis, starting at week four, significant differences were found between 
males and females in overall average run time with males running a significantly longer 
duration than females (p=0.035; data not shown).  Repeated measures also showed 
significant differences between exercise endurance tests across weeks in the female 
mice (p=0.041).  The coefficient of variation within each mouse between exercise 
endurance tests over the 10 weeks was very high for both males and females (average 
CV= 37.0, CV= 51.0 respectively).  Further, there wre large average percent 
differences within mice between endurance tests for both males (287±316%, 
mean±SD), females (521±568%), and the total group (404±463%) (Fig. 3).  No 
technician bias was found to have been associated wi h the variation in endurance 
scores (p>0.05, t=1.97) and body weight was not correlated with endurance 
performance (males, r=0.26; females, r= -0.15). 
 In regard to wheel running repeatability, female and male mice exhibited similar 
repeatability measures in distance, duration, and speed (data not shown).  Thus, when 
all mice were pooled, there were no significant differences found between days 5 and 6 
in distance, duration, or speed (Fig. 4).  Additionally, high correlations between days 5 
and 6 (distance, r=0.74; duration, r=0.74; speed, r=0.85) indicate repeatability within 
mouse for physical activity measurements. 
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Discussion 
 Over the past several years, studies examining both maximal endurance 
phenotypes and physical activity phenotypes in rodents have been reported in an effort 
to assess the genetic/biological factors involved in the regulation of these exercise 
behaviors (59, 129, 142, 149, 151, 153, 195, 200, 253 79).  Given the relative 
consistency of these measures of exercise behaviors in humans (e.g. VO2max tests) and 
in smaller reported cohorts of mice, all of which assessed repeatability of VO2max 
measurements (20, 79, 195), it has been natural to assume that these measures were 
repeatable in mice.  In addition, given the fact that VO2max is a good predictor of 
exercise endurance in humans (17, 42), and has been shown repeatable, the assumption 
could be made that maximal endurance tests used to assess endurance in rodents (15, 
129, 150, 280) would also be repeatable.  Our finding of within strain stability of overall 
endurance in different cohorts of mice over a six year period (Fig. 1) and the 
repeatability of voluntary physical activity measurements (Fig. 4) support this 
assumption.  However, over the course of several years, and a number of studies, a lack 
of consistency in repeat testing of mouse maximal endurance became apparent in our 
lab (Fig. 2).  This evidence, led us to conduct the 10 week repeatability of max 
endurance outlined in Table 1, and combined, these data raise questions regarding the 
repeatability of this method of maximal endurance measurement in mice. 
Forced Maximal Endurance Tests 
 Conducting endurance treadmill tests in rodents can be difficult.  It has been 
noted (20, 132) that anywhere from 10-25% of rodents will refuse to run on a treadmill, 
even with orientation exposures.  Given the difficulty of having rodents perform forced 
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endurance tests, it is surprising that relatively fw studies have reported repeatability 
results of maximal exercise endurance or VO2max using a graded treadmill protocol in 
mice.  Rezende and colleagues (195) measured VO2max during endurance treadmill tests 
in mice (n=48) selectively bred for high wheel running and reported repeatability of 
VO2max during treadmill tests as r=0.42.  Uniquely, Rezende and colleagues also 
reported using a subjective scale to assess the quality of the treadmill tests.  Any “poor 
trials” were not included in the analysis (195) suggesting that there was some 
acknowledgment that animals may not repeatedly run to exhaustion. 
 Other interpretations of rodent exercise capacity repeatability may be hampered 
by methodological limitations. Bedford and colleagues (20) tested the repeatability of a 
ten-stage graded treadmill test in rats (n=18) and reported a reliability coefficient of 
0.97.  However, Bedford and colleagues operationally defined VO2max as “one in which 
there is less than a 5% increase in VO2 with increase in work intensity.”  This 
operational definition was different than what is normally used in literature - allowing 
the rodent to run to exhaustion - and this operation l definition difference may 
contribute to their observation of higher repeatability values compared to other studies.  
We have noted that even in using four different rodent metabolic carts and three 
different forced exercise modalities, that oxygen co sumption values in rodents often 
peak very early in a forced endurance test and then decline in spite of continued 
increases in workload.  Speculatively, this type of response is most likely due to the 
common set-up of most commercially available rodent exercise metabolic chambers 
which allows the animal to remove their ventilatory stream from the gas sampling 
airstream when the mouse runs farther back on the treadmill.   Support for this 
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suggestion comes from earlier work by Friedman et al. (79) that tested the repeatability 
of several locomotor behaviors in random bred ICR mice (n=38) and reported a 
repeatability for VO2max of r=0.809.  In this study, the authors used the peak VO2 
measurement during a test as the VO2max regardless of whether this peak measurement 
occurred at the end of the test when mice were exhausted and unwilling to run farther or 
if the peak was reached earlier in the test but the animal continued to run beyond this 
point.  Thus, our observations, combined with both Friedman and colleagues’ (79) and 
Bedford et al.’s (20) studies suggest that repeatability of a forced exercise test in a 
rodent may depend upon the operational definition of the primary measure (e.g. VO2max) 
used as well as the testing equipment used. 
 Since measurement of maximal aerobic capacity in rodents can be challenging, 
graded treadmill protocols have also been used to measure maximal endurance without 
measurement of VO2max (15, 129, 150, 280).  To date, repeatability of exercise 
endurance measures using this type of protocol has not been reported.  Koch et al. (129) 
initially implemented an endurance testing protocol which consisted of a week of 
increasing orientation bouts on a treadmill, followed by endurance max testing in the 
second week for five consecutive days to assess heritability of exercise endurance in 
rats.  These authors reported that within sex, variation in the five consecutive max 
endurance tests “was found not to be different from a normal distribution”.  However, in 
none of the publications where this endurance testing model has been used, has it been 
noted whether the five tests differed significantly from each other, nor whether possible 
physiological training effects of the five consecutive max tests occurred.  Regardless of 
whether these items were considered, the exhibition of a normal distribution across 
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repeated testing does not indicate repeatability.  For example, in the current study, the 
repeated testing we did over a ten-week time period (Table 1, and Fig. 3), was still 
normally distributed (Shapiro-Wilk W test, p=0.12) in spite of exhibiting an 
approximately 400% difference in day to day results and virtually no test-test significant 
association.  Therefore, a set of repeated measures can have a normal distribution, yet 
be significantly different within-subject and thus, not be a repeatable test-test.  While it 
appears that measurement of VO2max in rodents may be repeatable under specific 
conditions, the data found in our study (Table 1, Fig. 2, and Fig. 3) indicate that 
measurement of endurance in mice (as assessed by time to exhaustion in a sealed 
treadmill chamber using shock grid for motivation) may not be repeatable. 
 Indeed, one possibility for the lack of repeatability within our studies was the 
use of a sealed metabolic chamber with shock grid.  During our early use of an open 
treadmill which allowed manual encouragement of running (using tail tapping – see Fig. 
1) we observed significant repeatability within strain, even across several years.  The 
use of an enclosed treadmill, while necessary for metabolic measures, eliminates the 
possibility of using manual encouragement, as a supplement for electric shock, for the 
mice to continue running.  While we do not have repeated measures of exercise 
endurance within mice using an open treadmill, this is an observation that bears further 
explanation. 
 Another possibility to explain the lack of repeatability we observed using the 
sealed treadmill with electric shock is that this type of testing may be more of a 
psychological stressor to the animal than other execis  measurements such as voluntary 
wheel running.  This hypothesis is supported indirectly by several studies.  First, the use 
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of various means of motivation for running during forced treadmill tests (e.g. electric 
shock, puffs of air, tapping of the tail) may induce a negative response in the animal 
similar to that of chronic psychological stress, and this could mask true exercise 
behaviors (172).  One such negative response is theobs rvation that brain derived 
neurotrophic factor (BDNF) decreases after forced exercise in animal models similar to 
the effects seen during immobilization stress (3, 4).  However, in humans, treadmill 
exercise has been shown to have beneficial effects on he brain including increased 
BDNF levels (68) contributing to an antidepressant effect (63).  Thus, treadmill exercise 
in rodents may not be an appropriate model for the comparison of the response to 
treadmill exercise in humans due to the psychological stress to the rodent, which may in 
turn contribute to this measurement being non-repeatable in mice. 
 The difference observed between the repeatability of exercise endurance in male 
and female mice during the repeated 10 week endurance study was unexpected, but may 
be related to the time of measurement within the estrou  cycle.  Female mice were only 
endurance tested during the diestrous phase of their cycles which corresponded to 
periods of low estrogen.  There have been no studies investigating the effects of the 
estrous cycle on exercise endurance in rodents; however, numerous other studies have 
suggested that estrogen may play a role in the regulation of overall physical activity 
patterns (202).  Thus, while it cannot be definitively concluded that the low estrogen 
levels are responsible for the sex difference seen in average exercise endurance in this 
study, the wide test-to-test variation seen in both females and males across time 
(averaged 404±463%, Fig. 3) and the lack of significant test-test association (Table 1) 
lends support to the finding that exercise endurance measured in a sealed treadmill is 
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not repeatable.  Furthermore, the observation of no significant differences in exercise 
endurance between the 10 repeated tests in the male mice may have occurred because 
the variation between tests were so large that statistic l significance may have been 
undetectable.  This hypothesis is supported by the large test-to-test variation in both the 
male and female mice and was further mirrored in the large average percent differences 
between endurance tests for both males and females (Fig. 3).  Additionally, it is worth 
noting that none of the animals in this maximal treadmill protocol actually reached the 
end of the protocol before stopping; thus, variation in the endpoints of the protocol did 
not contribute to the overall variation observed.  Therefore, although males and females 
were significantly different in average run time on the endurance tests, both sexes were 
similar in their lack of repeatability in this measure.  The overall average percent 
difference of 404±463% in maximal exercise endurance we observed with repeated 
testing is relevant given the repeatable nature of maximal endurance testing in humans 
(8-10%) (162) and the growing number of studies that are using maximal endurance 
testing without repeatability monitoring to distinguish between treatments in animals 
(173, 291). 
Voluntary Physical Activity (Running Wheel) 
 Our large cohort data in addition to the available literature suggest that physical 
activity as measured by running wheel activity in rodents is a repeatable phenotype 
(Fig. 4).  Swallow and colleagues (253) reported high repeatability of running wheel 
activity on days 5 and 6 of measurement in selectivly bred mice (n=287 females 
r=0.787; n=273 males r=0.868).  In addition, Rezende and colleagues measured VO2max 
during wheel running in selectively bred female mice (n=48) and reported repeatability 
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of VO2max measurements during running wheel activity as r=0.844 (195), indicating 
both running wheel activity, and VO2max achieved during wheel activity are repeatable.  
Similar to humans, levels of BDNF increase in the brain following voluntary physical 
exercise in mice (21), possibly helping to explain the repeatability of this phenotype in 
rodent models. 
 It is also warranted to speculate that the repeatability of wheel running in 
rodents is due to the voluntary and perhaps innate ture of this activity.  Rowland 
(208) described the idea of an intrinsic biological ontrol of energy expenditure in 
animals.  From an evolutionary standpoint, it would be beneficial for organisms to 
maintain energy balance, and he proposed this was done by an “activity-stat” 
mechanism.  Rowland proposed several lines of evidence, including genetics, for this 
“activity-stat” mechanism which would theoretically work centrally to control amount 
of intrinsic physical activity, and thus, energy exp nditure (208).  Supporting the 
hypothesis of an “activity-stat” is the observation that genetically different strains of 
mice differ in the level of voluntary wheel running (149).  Because this “activity-stat” 
would be regulated centrally and would be intrinsic to individual animals, this could 
explain why the measurement of voluntary physical ativity has been shown to be 
repeatable in the rodent literature. 
Conclusions 
 In conclusion, while average exercise endurance within strain measured with an 
open treadmill across time appears to be stable, exercise endurance measurements using 
sealed treadmills repeated on the same mouse are not peatable.  Crabbe and 
colleagues (43) employed a well designed study to show that inbred strains of mice 
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differ in behavioral phenotypes depending on the labor tory setting.  Even though 
different technicians and slightly different laborat ry settings were employed for the 
different cohorts of mice outline in Figure 1, these two strains, as groups, tested the 
same over time.  The different reported values for repeatability of VO2max testing in 
rodents in the literature could be partially explained by the evidence presented by 
Crabbe and colleagues; however, in the current study, even when repeated maximal 
endurance testing in the same lab, under the same conditions, with the same technicians 
was employed (Table 1) the results indicate high variability in this behavioral test.  It 
may be possible to reliably endurance test rodents using other methods; however, the 
results in this study indicate using an enclosed tradmill with a shock grid for aversive 
stimuli that produces a negative stimulus to encourage mice to run to “exhaustion” is 
not a repeatable measure for assessing exercise endurance in mice.  In contrast, daily 
physical activity as assessed by distance, duration, and speed on a running wheel 
appears highly repeatable in both inbred and outbred mice.  The level of voluntary 
physical activity an animal performs appears to be both genetically and biologically 
regulated possibly influencing the high repeatability of this phenotype.  The 
observations in this study are critical in considering results from current and future 
exercise behavior literature that investigates the rol  of various biological factors 
involved in the regulation of exercise behaviors in rodents. 
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Figure 1:  Average time run of two different cohorts of Balb/cJ and DBA/2J mice 
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Figure 1:  Average Time (and standard deviations) i minutes of two different cohorts 
of Balb/cJ mice and DBA/2J mice.  No significant differences were found between 
years within either strain (Balb/cJ mice, p=0.55; DBA/2J mice, p=0.51).  
 
 
 
 
Figure 2:  Comparison of endurance Test 1 vs. Test 2 in 80 F2 mice 
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Figure 2:  F2 animals classified as high runners were significantly higher than those 
classified as low runners in each test (p<0.001).  Test 2 endurance results were 
significantly different than test 1 endurance results within each group (p<0.001).            
* indicates a significant difference between test 1 and test 2, within group. 
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Table 1:  Correlation Values of Endurance for Each Week of Testing in 20 Balb/cJ 
     mice 
 
Week 1 2 3 4 5 6 7 8 9 10 
1 --- .27 .34 -.15 .23 .02 -.08 -.08 -.04 .25 
2  --- .35* .35 .21 .16 .47 .03 .05 .41 
3   --- .08 .44 .12 .30 .10 -.08 .34 
4    --- .16 .75 .76 .66 .41 .38 
5     --- .33 .30 .10 .22 .44 
6      --- .51 .52 .62 .33 
7       --- .55 .24 .51 
8        --- .42 .47 
9         --- .18 
10          --- 
* = significance at p<0.05 
 
Table 1:  Ten Balb/cJ male and ten Balb/cJ female mice were endurance tested once a 
week for ten weeks.  No differences in association between max endurance tests were 
attributed to sex, thus matched pairs correlation values are shown in the table for all 
mice for all ten weeks.  In addition, average coefficient of variation: males CV=63.5, 
females CV=118.5.  Repeated measures ANOVA showed no sig ificant differences in 
male mice across weeks (p=0.33), but there were significant differences in female mice 
across weeks (p=0.04) (data not shown).   
 
 
Figure 3:  Average percent differences between 10 consecutive endurance tests in male 
       and female Balb/cJ mice. 
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Figure 3:  Average percent differences (± standard eviations) between endurance tests 
in male Balb/cJ mice (n=10), and female Balb/cJ mice (n=10). 
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Figure 4:  Comparison of wheel running indices between day 5 and 6 of wheel running 
       exposure in inbred and outbred mice. 
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Figure 4:  Comparison of wheel running indices between day 5 and 6 of wheel running 
exposure in inbred and outbred mice (n=739).  No significant differences were found 
between the two days of measurement for any index (Distance, Km/day; duration, 
min/day*100; and speed, m/min).  Correlation values are also reported for each index. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3: 
ALTERED DOPAMINERGIC PROFILES: 
IMPLICATIONS FOR THE REGULATION OF VOLUNTARY  
PHYSICAL ACTIVITY 
 
 
Abstract: 
 The biological regulating factors of physical activity in animals are not well 
understood.  This study investigated differences in ce tral mRNA expression of seven 
dopamine genes (Drd1, Drd2, Drd3, Drd4, Drd5, TH, and DAT) between high active 
C57/LJ (n=17) male mice and low active C3H/HeJ (n=20) male mice, and between 
mice with access to a running wheel and without running wheel access within strain.  
Mice were housed with running wheels interfaced with a computer for 21 days with 
distance and duration recorded every 24 hours. On day 21, the striatum and nucleus 
accumbens were removed during the active period (~9pm) for dopaminergic analysis.  
On average, the C57L/J mice with wheels ran 99% farther, 98% longer, and 65% faster 
than the C3H/HeJ mice with wheels over the 21 day period.  No differences in gene 
expression were found between mice in either strain with wheels and those without 
wheels suggesting that access to running wheels did not alter dopaminergic expression.  
In contrast, relative expression for two dopamine genes was significantly lower in the 
C57L/J mice compared to the C3H/HeJ mice.  These results indicate that decreased 
dopaminergic functioning is correlated with increasd activity levels in mice and 
suggests that D1-like receptors as well as Tyrosine Hydroxylase (an indicator of 
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dopamine production), but not D2-like receptors are associated with the regulation of 
physical activity in inbred mice. 
Key Words:  dopamine, locomotion, running wheel, mice, dopamine receptor, striatum, 
nucleus accumbens 
Introduction: 
It is axiomatic that physical activity is important to human health.  Given the 
known benefits of physical activity, it is imperative to understand the mechanisms that 
regulate this behavior.  It has been well established in both human and animal models 
that genetic factors significantly influence physical activity levels (69, 119, 135, 138, 
142, 149, 153, 249, 262).  However, the identity of which systems or genes are involved 
in the regulation of activity level is currently unclear.   
The central function of the dopaminergic system is to control motivation for 
natural rewards and motor movement (285), and several studies in rodents suggest 
certain aspects of dopaminergic functioning may contribute to the genetic/biological 
regulation of physical activity (29, 198, 200, 235).  The dopamine system has also been 
implicated in movement disorders such as Attention Deficit Hyperactivity Disorder 
(190), and Parkinson’s Disease (130), making it a likely candidate to be involved in 
regulating voluntary activity. 
 Several studies have linked D1-like and D2-like dopamine receptors to various 
aspects of locomotion in animals (10, 11, 29, 55, 99, 122, 164, 235).  However, the term 
“locomotion” in animal literature simply refers to he act of movement, which can 
encompass a wide variety of specific definitions depending on the methodology used.  
Voluntary physical activity, which is commonly defined as purposeful exercise or 
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movement that expends a significant amount of energy, appears to be a separate 
phenotype from locomotion, and no studies have been conducted to investigate the role 
of the dopaminergic system in the regulation of v luntary physical activity in inbred 
strains of mice.  Artificial selection studies in mice have shown that mice bred for high 
wheel running activity not only have high motivation for natural rewards such as 
exercise, food, and sex, they also respond differently than controls to drugs such as 
Cocaine or Ritalin which act by blocking the dopamine transporter (200).  In addition, 
Rhodes and colleagues found that D1-like antagonists reduced wheel running more in 
control line mice compared to selected animals, while D2-like antagonists had similar 
effects on both selected and control mice, suggesting D1-like receptors may be 
important in mediating the increased wheel running in the selected animals (199). Fink 
and Reis, 1981, showed that Balb/cJ mice have more dopamine activity in both the 
nigrostriatal, and mesolimbic pathways in the brain compared to CBA/J mice (70) 
suggesting that differences in the dopamine system ar  genetically determined in mice, 
and that these differences may translate into behavioral differences in motivation for 
physical activity.   
Whilst dopaminergic functioning may act as an independent variable to regulate 
physical activity, it has also been shown that changes in the dopamine system such as 
increased dopamine activity and/or neural synthesis can be dependent upon physical 
activity (212, 259, 276, 290).  From the current studies available (29, 70, 199-201, 235) 
it is unclear if dopamine functioning is acting independently on physical activity levels 
or if physical activity is affecting dopaminergic functioning. Therefore, this study 
investigated whether the dopamine system acts as the dependent or independent 
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variable in the regulation of physical activity by assessing expression differences in 
seven dopamine related genes in the striatum/nucleus accumbens area of the brain.   
Methods: 
Animals: 
 C57L/J mice, previously shown to be high active animals and C3H/HeJ mice, 
previously shown to be low active animals were used in this study (149). Both strains 
have been inbred past 130 generations, were purchased from The Jackson Laboratory 
(Bar Harbor, ME), and have no phenotypic abnormalities that would confound this 
study.   Only male mice were used in this study to av id possible confounding effects of 
the menstrual cycle on daily physical activity in female mice (7).  All mice were housed 
in the University Vivarium with 12 hour light/dark cycles and were provided food 
(Harlan Teklad 8604 Rodent Diet, Madison, WI) and water ad libitum.  All procedures 
were approved by the University of North Carolina Charlotte Institutional Animal Care 
and Use Committee. 
 In order to investigate whether the dopamine system is acting in a dependent or 
independent fashion in the regulation of physical ativity, mice from each strain were 
randomly assigned to experimental groups housed with running wheels (C57L/J, n=10; 
C3H/HeJ, n=10), or control groups housed with no running wheels (C57L/J, n=7; 
C3H/HeJ, n=10).  Each group was housed and treated the same other than the presence 
of a wheel in the experimental group.  All mice were approximately 9 weeks of age at 
the beginning of the study.  Only 7 control C57L/J mice were used because of difficulty 
in supply availability from The Jackson Laboratory. 
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Measurement of Voluntary Daily Activity Level: 
 Daily wheel running in mice was chosen as the model f human voluntary 
physical activity level (61) and was measured using methods described previously (149, 
153).  Briefly, mice were housed individually with a running wheel (450mm 
circumference; Ware Manufacturing, Phoenix, AZ) mounted in each cage.  The wheels 
were equipped with a magnet mounted on the outside surface and the top of the cage 
was equipped with a magnetic sensor (BC500; Sigma Sport, Olney, IL).  Each cage 
computer was calibrated for the circumference of the cage wheel allowing for accurate 
measurement of distance (km) and time the animals ran on the wheel (duration in min).  
The data were collected every 24 hours for 21 days and the wheels were checked 
manually each day to assure sensor alignment and free-tu ning.   Speed of activity 
(m/min) was calculated by dividing daily distance by daily duration of exercise.   
Additionally, weight of all animals was recorded weekly. 
Molecular Analysis: 
 Brains were harvested whole as described previously (29) and the striatum and 
nucleus accumbens area was dissected over ice and immediately flash frozen in liquid 
nitrogen and stored at -80°C.  Tissues were harvested between 9 pm and 12 am, 
corresponding to hours 4 through 6 of the active cycle (12 hour light/dark cycle with the 
dark cycle between 6pm and 6am) in order to capture dopaminergic activity during the 
active period. 
 Quantitative real time RT-PCR was conducted using tandard protocols to 
analyze mRNA expression of the following dopaminergic genes: dopamine receptor 1 
(Drd1), dopamine 2 receptor (Drd2), dopamine 3 receptor (Drd3), dopamine 4 receptor 
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(Drd4), dopamine 5 receptor (Drd5), tyrosine hydroxylase (TH), and the dopamine 
transporter (Slc6a3 also known as DAT).  Primers were designed using Primer 3 (Steve 
Rozen and Helen J. Skaletsky) (210) and ordered from Integrated DNA Technologies 
Inc (San Diego, CA).  Total mRNA from the striatum and nucleus accumbens samples 
were isolated using trizol reagent (Sigma-Aldrich, Saint Louis, MO), and cDNA was 
prepared using QuantiTect Rev. Transcription Kit (QIAGEN, Valencia, CA).  Real time 
analysis was conducted using QuantiTect SYBR Green PCR Kit (QIAGEN, Valencia, 
CA) and the LightCycler®1.5 Carousel-Based System (Roche Applied Science, 
Indianapolis, IN).  All dopamine receptor mRNA expressions were normalized to an 
endogenous positive control (beta-actin) using methods as described previously (185). 
Statistics: 
 Two-way ANOVA (JMP 7.0, SAS Institute, Cary, NC) was used to compare 
expression of all seven genes for the main effects of strain (C57L/J high active or 
C3H/HeJ low active) and group (wheel-running or non-wheel running).  The alpha 
value was set at 0.05 and Tukey’s HSD post-hoc tests were used when significant main 
effects were present to evaluate strain by group interactions. 
Results 
Voluntary Physical Activity 
 As expected from past research, the C57L/J mice wersignificantly more active 
than the C3H/HeJ mice (Figure 1).  C57L/J mice with wheel access ran significantly 
farther (10.25±1.37 km/day vs. 0.01±0.09 km/day, p<0.001), longer (329.73±30.52 
mins/day vs. 7.81±6.32 mins/day, p<0.001), and faster (31.27±3.13 m/min vs. 
11.81±1.08 m/min, p<0.001) than C3H/HeJ mice with wheel access during 21 days of 
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wheel running data collection.   There was no difference (p=0.67) in starting weights 
between C57L/J mice (25.6±1.0g) and C3H/HeJ mice (25.6±1.1g).  There were also no 
significant differences (p>0.05) in weight within C3H/HeJ mice between group or over 
time [Control group: beginning weight=25.8±0.9g, end weight=26.1±1.5g; Running 
wheel group: beginning weight=25.8±1.2g, end weight=27.0±1.4g].  Additionally, 
within the C57L/J mice, no significant changes in weight were seen over time within 
group (p>0.05); however, C57L/J control mice weighed significantly more (p<0.05) at 
the end of the study than C57L/J running wheel mice at the beginning of the study 
[Control group: beginning weight=26.1±1.5g, end weight=26.8±1.3g; Running group: 
beginning weight=25.3±0.7g, end weight=26.5±0.9g]. 
mRNA Expression 
 No significant differences in expression of any of the genes were found between 
wheel-running and non-wheel-running groups within each strain (Figure 2 and Figure 
3).  However, significant differences were found between strains in the expression of 
the dopamine genes.  The expression of Drd1 (p<0.0001, power=0.90), and TH 
(p=0.0008, power=0.90) (Figure 4) were markedly different between the high active and 
low active mice.  C57L/J mice (high active) expressed ignificantly lower amounts of 
mRNA of each of these genes in the striatum/nucleus accumbens than did the C3H/HeJ 
mice (Figure 4).  Expression of Drd5 (p=0.05; power = .44) bordered on significance 
between strains; however, this marginal difference i  Drd5 is not surprising considering 
that Drd1 and Drd5 are in the same sub-family of dopamine receptors.  No differences 
in gene expression between strains were found for Drd2 (p=0.01; power =0.4), Drd3 
(p=0.21; power =0.2), Drd4 (p=0.27; power =0.2), and DAT (p=0.83; power =0.05). 
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Discussion 
 The genetic and biological regulating factors of physical activity are only 
beginning to be understood.  This study showed that genetically different strains of mice 
not only differ in their physical activity levels, but that these differences are perhaps 
mediated at least in part by the dopamine system.  Specifically, it was shown that 
C57L/J male mice run significantly farther, longer, and faster than C3H/HeJ male mice 
(Figure 1).  No differences in expression of any of the dopamine receptors, as well as 
TH, and DAT genes were found as a result of access to a running wheel thus suggesting 
that activity was not altering dopaminergic expression levels.  Finally, significant 
differences were found between the high and low active animals for both Drd1 and TH 
dopaminergic genes.  Both Drd1 and TH were expressed at significantly lower levels in 
C57L/J (high active) mice compared to the C3H/HeJ (low active) mice.  In conjunction 
with past literature relating dopaminergic functioning with activity, our results further 
support the hypothesis that the dopaminergic system independently regulates physical 
activity possibly through the Drd1 receptors and tyrosine hydroxylase.  
 The results of this study highlight an important first step in the understanding of 
the genetic/biological regulation of physical activity.  Voluntary physical activity has 
been shown to have a significant genetic component underlying the manifestation of 
this trait.  Heritability studies estimate the genetic contribution to physical activity 
ranges from 20-80% (69, 135, 142, 149, 184, 262).  Recent studies by Lightfoot and 
colleagues have also begun to elucidate possible quantitative trait loci (QTL) associated 
with regulation of physical activity in mice including a QTL that contains the Drd1 
gene (153).  With this being said, biological (non-genomic) factors have also been 
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proposed as possible regulators of physical activity.  For example, the sex hormones 
have been shown to significantly affect physical activity in rodents (96, 148, 179).  It is 
warranted to speculate that the dopaminergic system may act in both a genetic and 
biological (non-genomic) manner in the regulation of physical activity.  From a genetic 
standpoint, the current study highlights the possible importance of differences of overall 
expression of various dopaminergic genes (in particular Drd1 and TH) in the mid-brain 
in mediating differences in physical activity levels between genetically different inbred 
strains of mice.  However, it has also been proposed that the dopamine system may also 
be influenced by biological factors such as the sex hormones and this interaction may 
also be important to the regulation of physical activity (148).    
 Within the genetic component, it is unclear as to whether the genes regulate 
differences in physical activity levels between indivi uals through peripheral or central 
mechanisms.  Several studies conducted using mice bred for high wheel running 
activity indicate a possible “central” regulation of physical activity as opposed to 
peripheral factors such as mitochondrial number, and/or muscle fiber type differences 
(59, 85, 89, 111, 112).  Specifically, mice bred for high wheel running have altered 
regional brain activation profiles compared to contr l mice (200), as well as respond 
differently to dopaminergic acting drugs (199, 201).  Thus, in this paper we 
hypothesized the dopamine system is an important central genetic factor involved in the 
regulation of physical activity behavior in inbred strains of mice.  Similarly, the nucleus 
accumbens/striatum were investigated in this study because this area of the midbrain 
has been implicated in motor movement as well as motivation and reward behaviors 
(213).   
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 It is well known that the dopamine system is important in mediating certain 
aspects of locomotion in animals.  In addition to the dopamine system’s known role in 
the motor movement disabilities manifested in Parkinson’s disease (114), dopaminergic 
functioning has also been implicated in the hyperactive phenotype typical of Attention 
Deficit Hyperactivity Disorder (ADHD).  The results of the current study suggest that 
high active mice have lower overall dopamine production and decreased dopamine 
signaling through D1-like pathways compared to low active mice.  This result 
corresponds to research showing that the hyperactive phenotype appears to be a result 
of lower dopamine presence in the synapse and thus altered overall dopamine signaling 
in ADHD (144, 159).  Ritalin improves symptoms of ADHD by blocking the dopamine 
transporter (DAT) and effectively increasing the amount of dopamine in the synapse.  
Similarly, when given cocaine or GBR 12909, both DAT inhibitors, mice selectively 
bred for high amounts of wheel running decreased thir wheel running more than 
controls (201).  We did not find a difference in the expression of DAT in the current 
study; however, this differential finding may be due to differences between the 
mechanistic underpinnings of high activity versus ADHD.  Nevertheless, it is intriguing 
that the high active mice in this study had significantly lower amounts of TH in the 
striatum and nucleus accumbens area compared to low active mice indicating the 
amount of dopamine production and turnover is lower in high active inbred mice, and 
may be important for overall physical activity levels. 
 In addition to the dopaminergic role in general motor movement and locomotion 
aspects such as Parkinson’s disease and ADHD, studie  have begun to suggest the 
dopamine system may play a key role in motivation for movement as well.  Rhodes and 
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Garland investigated the effects of several dopaminerg c acting drugs on wheel running 
in mice bred for high amounts of wheel running and compared their responses to control 
line mice.  They found that apomorphine (a non-selectiv  dopamine agonist) and SCH 
23390 (a selective D1-like antagonist) decreased wheel running more in the control 
lines compared to the selected lines, while treatmen  with raclopride (a selective D2-like 
antagonist) had similar effects on wheel running in both the selected and control lines 
(199).  The authors suggested these results indicate  the selected animals had a 
decreased function of the D1-like receptors, but not the D2-like receptors, and these 
differences may mediate motivational differences for high voluntary amounts of 
running in the selected animals.  Our results correspond with the results from Rhodes 
and Garland, in that a decreased function of the D1-like receptors in a high active inbred 
strain compared to a low active inbred strain of mice was apparent, and suggests these 
receptors are important in the regulation of physical activity behavior, possibly in the 
form of motivation for this voluntary behavior.   
 It has been unclear whether the dopamine system acts as a dependent or 
independent factor in the regulation of physical activity.  It has been shown that 
exercise causes changes in neurotransmitter systems, including an increase in dopamine 
production, and these responses lead to beneficial changes at the molecular and cellular 
levels including increased neuronal plasticity, cognitive functioning, learning, and 
overall mood (53).  The neurotransmitter alterations is a primary reason that exercise is 
often used in the treatment of depressive disorders (28).  While activity may influence 
dopaminergic functioning independently, the previous work, especially that from 
Garland’s group as well as the known role of the dopamine system in regulation of 
 71 
 
motivation and reward (50, 214), led us to hypothesize an independent role of the 
dopamine system in the genetic/biological regulation of physical activity.  Our findings 
of similarities in brain dopaminergic gene expression within strain, regardless of 
whether the mice were exposed to a running wheel, suggests that expression levels of 
these genes are not necessarily subject to fluctuation based on activity levels and thus 
do not act in a dependent fashion in this case.  The differences we observed between 
strains in Drd1 and TH suggest that these particular genes may be acting in an 
independent fashion in mediating the large differences seen in activity levels between 
these two strains of mice. 
 The evidence presented in this study is an important first step to understanding 
the multifaceted genetic and biological regulation of voluntary physical activity levels.  
As mentioned previously, the genetic contribution t regulation of physical activity 
ranges from 20-80%; however, we are only beginning to understand the genetic 
regulating factors of this behavioral trait.  The pr sent study suggests the dopamine 
system may be an important central genetic factor involved in regulation of physical 
activity.  In addition, this study is the first to highlight the fact that the dopamine system 
appears to act as an independent variable in the regulation of physical activity in mice, 
and specifically lower expression of the D1 receptor, as well as tyrosine hydroxylase in 
the mid-brain, may possibly mediate the high activity seen in the C57L/J strain.  Given 
that the dopamine system itself is influenced by factors such as nutritional status, and 
hormones and that the dopamine system also regulates sev ral downstream signaling 
pathways leading to differential gene expression, the central regulation of voluntary 
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physical activity is an intriguing avenue of study and certainly bears significance in the 
prevention of inactivity related diseases. 
Acknowledgements: 
 The authors would like to thank the Schrum lab in the Department of Biology at 
UNC Charlotte for providing space in their lab for the preparation of real-time analysis 
materials.  We would also like to thank the UNC Charlotte Vivarium staff.  The project 
described was supported by NIH NIAMS AR050085. 
Footnotes: 
 
Authors:  Amy M. Knab1, Robert S. Bowen1, Alicia T. Hamilton1, Alyssa A. 
Gulledge2, J Timothy Lightfoot1 
1 Department of Kinesiology, University of North Carolina, Charlotte NC 
2 Department of Biology, University of North Carolina, Charlotte NC 
Journal Submission:  At the time of publication of this dissertation, the following 
chapter was in review for publication in the journal:  Behavioural Brain Research. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 73 
 
Figure 1:  Average distance, duration, and speed for C57L/J and C3H/HeJ mice over 21 
      days.  
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Figure 1: Average distance, duration, and speed for C57L/J (n=10) and C3H/HeJ (n=10) 
mice over 21 days.  A.  Average distance (Km/day) for C57L/J (10.25±1.37) and 
C3H/HeJ (0.01±0.09).  B.  Average distance (mins/day) for C57L/J (329.73±30.52) and 
C3H/HeJ (7.81±6.32) mice.  C.  Average speed (m/min) for C57L/J (31.27±3.13) and
C3H/HeJ (11.81±1.08) mice.  * designates significantly higher than C3H/He mice at 
p<0.001. 
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Figure 2:  Gene expression in the striatum/nucleus accumbens tissue of C3H/HeJ mice 
       housed with or without a running wheel. 
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Figure 2:  Gene expression in the striatum/nucleus accumbens tissue of C3H/HeJ mice 
housed with a running wheel and C3H/HeJ mice housed without a running wheel.  No 
expression differences (p>0.05) were found between control (n=10) and running (n=10) 
C3H/HeJ mice for any of the seven dopaminergic genes. 
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Figure 3:  Gene expression in the striatum/nucleus accumbens tissue of C57L/J mice 
       housed with or without a running wheel.   
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Figure 3:  Gene expression in the striatum/nucleus accumbens tissue of C57L/J mice 
housed with a running wheel and C57L/J mice housed without a running wheel.  No 
expression differences (p>0.05) were found between control (n=7) and running (n=10) 
C57L/J mice for any of the seven dopaminergic genes.  
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Figure 4:  Comparison of dopaminergic gene expression between low active C3H/HeJ 
       mice and high active C57L/J mice. 
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Figure 4:  A significant main effect of strain was found for two dopaminergic genes 
(Drd1, and Tyrosine Hydroxylase).  The data in this figure represent all mice from each 
strain (control and experimental).  For each of these genes, C57L/J mice had 
significantly lower expression than C3H/HeJ mice.  p values are reported for each gene 
in the figure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4: 
PHARMACOLOGICAL MANIPULATION OF THE DOPAMINERGIC SYSTEM 
AFFECTS WHEEL RUNNING ACTIVITY IN DIFFERENTIALLY ACTIVE MICE. 
 
 
Abstract 
 The genetic factors involved in the regulation of physical activity are not well 
understood.  The dopamine system has been implicated in the control of voluntary 
locomotion and wheel running (WR) in mice and is thus a likely candidate as a 
genetic/biological system important to the regulation of physical activity.  Purpose: 
This study evaluated the effects of four different dopaminergic acting drugs on WR in 
differentially active inbred strains of mice.  Methods:  High active C57L/J (n=7, 3-
controls, 5-experimental) and low active C3H/HeJ (n=8, 3-controls, 5-experimental) 
were analyzed for baseline wheel-running indices of distance (km/day), duration 
(mins/day), and speed (m/min) for 21 days.  Experimntal mice received increasing 
doses over four days of each of the following drugs:  SKF 81297 (D1 agonist), SCH 
23390 (D1 antagonist), GBR 12783 (DAT inhibitor), and AMPT (tyrosine hydroxylase 
inhibitor).  Each drug dose response treatment was separated by three days of recovery 
(no drug injections).  WR indices were monitored during drug treatments and during 
drug wash-out phases.  Results:  SKF 81297 significantly reduced (p=0.0004) WR in 
the C57L/J mice, but did not affect WR in the C3H/HeJ mice.  GBR 12783 significantly 
increased (p=0.0005) WR in C3H/HeJ mice, but did not affect WR in C57L/J mice.  
Only duration (not overall WR) was significantly reduced in C57L/J mice in response to 
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SCH 23390 (p=0.003) and AMPT (p=0.043).  SCH 23390 (p=0.44) and AMPT 
(p=0.98) did not significantly affect WR in C3H/HeJ mice.  Conclusions:  These results 
suggest that genetic differences in dopamine signaling re important in the WR 
response to dopaminergic acting drugs in inbred strains of mice.  The high activity in 
the C57L/J strain is primarily mediated by D1-like receptors, while in the C3H/HeJ 
strain, activity is mediated through overall dopamine signaling determined by dopamine 
re-uptake. 
Key Words:  Dopamine, dopamine signaling, physical activity, inbred mice, genetics, 
regulation 
Introduction 
 It is well known that physical activity improves human health by decreasing risk 
of obesity (82, 146, 297), cardiovascular diseases (66), Type II Diabetes (250), 
depression (248), certain types of cancer (102, 25193), and overall mortality (105).  
Although the physiology of exercise has been well studied over the past 40 years, the 
genetic and biological regulating factors of physical activity have yet to be fully 
investigated and understood.  It has been estimated that physical inactivity is a leading 
cause of mortality, and contributes to increasingly higher health care costs in developed 
countries (180).  Therefore, in order to prevent disease and improve human health it is 
vital to understand the regulating factors of physical activity. 
 It has been shown that physical activity patterns are significantly regulated by 
genetic factors, with the estimated genetic component ranging from 20-80% (69, 119, 
135, 142, 149, 153, 184, 249, 262).  At least two studies have identified both single-
gene and epistatic quantitative trait loci (QTL) involved in the regulation of physical 
 79 
 
activity in mice; in particular, significant single-gene QTL have been found on 
chromosomes 9 and 13 (138, 153).  However, the exact genes involved in regulation of 
physical activity are yet to be discovered.  Selectiv  breeding studies conducted by 
Garland and colleagues also illustrate a significant ge etic component involved in the 
regulation of physical activity.  After 35 generations of selective breeding for running 
wheel activity, selected animals ran over 170% farther han control mice (197).  
Selection acting on genetic variation in the original outbred population of mice 
highlights a definite genetic component to the regulation of voluntary physical activity 
in mice. 
 Furthermore, it appears from several studies that factors in the central nervous 
system may play a key role in the genetic/biological regulation of physical activity in 
rodents (29, 199-201).  The dopamine system, part of the central nervous system, 
located in the mid-brain, plays a role in mediating locomotion (213) and motivation 
(214).  For example, it is known that depletion of d pamine neurons in the mid-brain 
are a major cause of the motor deficits seen in Parkinson’s disease (301).  Also, the 
hyperactive phenotype common in Attention Deficit Hyperactivity Disorder (ADHD) is 
also mediated through dysfunctions in dopamine signaling in the brain (8).  
Pharmacological studies in rodents confirm dopaminerg c involvement in locomotor 
behavioral responses to stimuli such as psychostimulant drugs (14, 16, 91, 92, 108, 211, 
223, 242); however, compelling evidence from wheel running studies in mice also 
implicates the dopamine system in mediating general voluntary physical activity levels.  
Specifically, Rhodes and Garland (2003) investigated th  effects of Ritalin (a DAT 
inhibitor), apomorphine (a non-selective dopamine agonist), SCH 23390 (a selective 
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D1-like antagonist), and raclopride (a selective D2-like antagonist) on wheel running in 
both selected and control animals (199).  A differential response to Ritalin was seen 
where the selected animals decreased wheel running in response to Ritalin, while the 
control animals increased wheel running.  At high doses of apomorphine, and all doses 
of raclopride, both control and selected animals markedly decreased their wheel running 
by the same proportion.  However, in response to SCH 23390 control line mice decrease 
wheel running more than selected animals (199).  Additionally, recent results from our 
lab exhibiting an independent relationship of dopamine D1 receptors and tyrosine 
hydroxylase genes with differentially active inbred mice in the nucleus accumbens and 
striatum area of the brain (126) indicate that D1-like receptors as well as the amount of 
dopamine present in the mid-brain are involved in regulating wheel running in mice. 
 Wheel running in animals has been suggested as a good model for daily physical 
activity in humans (61, 234).  Thus, studying wheel running responses to dopaminergic 
drugs may prove useful in elucidating the proposed independent mechanism by which 
the dopamine system mediates physical activity behavior.  Therefore, the purpose of 
this study was to investigate the wheel running respon es to several dopaminergic 
acting drugs in differentially active inbred mice.   This study is another step in the 
understanding of the central genetic and biological regulation of physical activity, and 
will be important for future studies investigating the mechanisms of this regulation and 
importance to human health and performance. 
Methods 
Animals 
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 Differentially active strains of inbred mice were used in this study:  C3H/HeJ 
mice (n=8 males) previously identified as low active (30), and C57L/J mice (n=6 
females, n=1 male) previously identified as high active (30).  The use of primarily 
female C57L/J mice, while not optimal, was unavoidable due to the extremely limited 
supply of these highly active mice (see below).  However, whereas comparisons are 
made primarily within mouse and versus control mice of the same sex, appropriate 
conclusions can be drawn from the use of both male and female mice in this study.   
The C3H/HeJ mice were purchased from Jackson Laboratories; however, given that 
C57L/J mice are no longer available from Jackson Labor tories (nor from other 
suppliers), the C57L/J mice used in this study were tak n from a small breeding colony 
our lab maintains.  These mice were the first generation inbred offspring from C57L/J 
breeder pairs purchased from Jackson Laboratories in Spring 2008.   
 Running wheel data were collected from the mice beginning at 63 days (9 
weeks) of age which corresponds to the most active period in the lifespan for mice 
(255).  All mice were housed in the University Vivarium with 12 hour light/dark cycles 
(light 6am-6pm, dark 6pm-6am) and were provided food (Harlan Teklad 8604 Rodent 
Diet, Madison, WI) and water ad libitum.  All procedures were approved by the 
University of North Carolina Institutional Animal Care and Use Committee.  
Additionally, all animals were weighed twice weekly. 
Measurement of Voluntary Activity (Wheel Running) 
 Daily wheel running was measured using methods described previously (149, 
153).  Briefly, mice were housed individually in standard rat sized cages, each equipped 
with a solid surface running wheel (450mm circumference; Ware Manufacturing, 
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Phoenix, AZ) mounted on the cage top.  A magnet was mounted on the outside surface 
of each wheel and the cage top was equipped with a magnetic sensor (BC500; Sigma 
Sport, Olney, IL).  Each computer was calibrated with wheel dimensions to allow for 
accurate measurement of distance (km/day) and time (duration-mins/day) each mouse 
ran on the wheel.  Speed of running (m/min) was then calculated from the distance and 
duration data.  Mice were monitored and data was collected every 24 hours at 
approximately 9am during baseline and drug wash-out phases of the protocol.  During 
drug treatments, data was collected immediately before drug treatment at 6pm (the 
beginning of the dark/active phase for mice), at 12am (6hrs post drug treatment), and 
again at 6am (12hrs post drug treatment). 
Drug Treatment 
 Evidence from our lab (126) and others (199, 201) suggest physical activity in 
the form of wheel running in mice is at least partially regulated by the D1-like 
receptors, the dopamine transporter (DAT), as well as possibly the expression and/or 
function of the tyrosine hydroxylase enzyme.  Thus, in this study, we used four different 
drug treatments: SKF 81297 (D1-like agonist; Tocris Bioscience, Ellisville, MO), SCH 
23390 (D1-like antagonist; Tocris Bioscience, Ellisvi le, MO), GBR 12783 (DAT 
inhibitor; Tocris Bioscience, Ellisville, MO), and DL-2-Methyl-3-(4-hydroxyphenyl) 
alanine (AMPT) (Tyrosine Hydroxylase inhibitor; Sigma Aldrich, St. Louis, MO). All 
drugs have been shown to be centrally active after in raperitoneal (IP) injection and 
were administered IP in a volume of 0.3mL per mouse.  Dose responses were 
investigated using the following consecutive drug doses (mg/kg):  SKF 81297 (0.5, 
0.75, 1.0, 1.25), SCH 23390 (0.5, 0.75, 1.0, 1.25), GBR 12783 (15, 20, 25, 30), and 
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AMPT (85, 90, 95, 100).  All doses were based on previous literature investigating 
locomotion responses in mice to these particular drugs. 
 Treatment procedures: At nine weeks of age, mice were housed with a wheel, 
and baseline activity patterns was assessed for 21 consecutive days in all mice.  Five 
mice from the C3H/HeJ strain and 4 mice (3 females, and 1 male) from the C57L/J 
strain were randomly chosen for the experimental drug t eatment group, leaving three 
mice in each strain serving as controls.  Control mice received saline injections only.  
The experimental animals received one injection (according to the dose schedule 
described above) at 6pm, at increasing doses for 4 c nsecutive days, followed by three 
full days of drug wash-out (i.e. no injections).  Wheel running was monitored at 12am 
and 6am during drug treatment, and every 24 hours dring drug wash-out.  This pattern 
was repeated for all four drugs in succession.   
Injection methods:  Each drug injection solution was made fresh each day 
immediately prior to injections and all drugs were dissolved in 0.9% sterile saline.  
Once the appropriate dose was dissolved, the solution was placed in a sterile syringe 
and filtered through a 0.2 micron filter during injection.  The C57L/J mice received the 
drugs in the following order: SKF 81297 (83-87 days old), SCH 23390 (90-94 days 
old), GBR 12783 (97-101 days old), and finally AMPT (103-106 days old).  Due to age 
differences upon arrival and the need to keep drug injections sterile the C3H/HeJ mice 
received the drug treatments in the following order:  GBR 12783 (83-87 days old), 
AMPT (90-94 days old), SKF 81297 (97-101 days old), and SCH 23390 (103-106 days 
old).   
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Statistics 
 Given the differential drug injections at differing ages, (e.g. the C57L/J mice 
received SKF 81297 at 83-87 days old, but the C3H/HeJ mice received this drug at 97-
101 days old), each strain was analyzed in a separate ANOVA for the effects of the four 
drugs on wheel running indices.  The alpha value was set a priori at 0.05.  Within 
strain, each drug was analyzed separately with a two-way ANOVA with group (control 
vs. experimental) and dose (repeated measure) as main effects.  Three dependent 
variables were analyzed including distance (km/day), duration (mins/day), and speed 
(m/min).  Tukey’s HSD post-hoc tests were used to evaluate main effects and group by 
dose interactions within the ANOVA model.  There were no statistical differences 
between wheel running indices taken at 6 hours post-injection or 12 hours post-injection 
(data not shown) and thus, only wheel-running data from 12 hour post-injection will be 
presented.  Differences in weight at baseline measur ments between strains, as well as 
differences in weights between group within strains, were analyzed using independent t-
tests, and correlation analysis was used to investigate relationships between weight and 
distance run. 
Results 
Weights 
 Mice were weighed twice weekly during this study to encompass one weight 
measurement during each drug treatment, as well as one weight measurement during 
drug wash-out.  C3H/HeJ (n=8 males) mice as a whole gr up were significantly heavier 
than C57L/J (n=6 females, n=1 male) mice at baseline, a d at all time points throughout 
the study (p<0.001).  Weight of the control versus the experimental animals did not 
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differ across the treatments (C3H/HeJ, p=0.20; C57L/J, p=0.66).  As has been shown in 
previous studies (149, 153) during baseline activity measurements, weight was not 
correlated with distance run in either strain (C3H/HeJ: p=0.11, r2=0.43; C57L/J: p=0.12, 
r2=0.36).  Speed was also not correlated with weight in either strain (C3H/HeJ: p=0.66, 
r2=0.03; C57L/J: p=0.93, r2=0.002).  Duration was significantly correlated with weight 
in both strains (C3H/HeJ: p=0.04, r2=0.54; C57L/J: p=0.02, r2=0.69).  Weight did not 
significantly increase over the course of the study in C3H/HeJ mice (p=0.69; beginning: 
28.0±1.6g; end: 29.9±2.2g), while weight did significantly increase in C57L/J mice over 
the course of the study (p=0.02; beginning: 23.6±1.1; end: 25.1±1.0).   
Baseline Physical Activity Results 
 Baseline wheel running indices for both strains of mice are illustrated in Figure 
1.  As was expected from previous literature, the C57L/J mice ran 191% farther, 177% 
longer, and 84% faster than C3H/HeJ mice (p<0.0001).  There was no difference 
between control and experimental mice at baseline in distance (p=0.52), duration 
(p=0.52), or speed (p=0.74) in the C57L/J mice.  Likewise, there was no difference 
between groups of C3H/HeJ mice at baseline in distance (p=0.22), duration (p=0.33), or 
speed (p=0.16). 
Drug Effects on WR in C57L/J Mice 
 Wheel-running distance, the product of duration of activity and speed of 
activity, responses in C57L/J mice to all four drugs are shown in Figure 2.  No 
significant dose response was seen in distance run after treatment with the D1 agonist 
SKF 81297 (p=0.72); however, SKF 81297 significantly reduced wheel running 
distance regardless of dose (Fig. 2; p=0.0004).  No significant differences in distance 
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were observed between group or by dose for the D1-antagonist SCH 23390 (p=0.12), 
the DAT inhibitor GBR 12783 (p=0.89), or the TH inhbitor AMPT (p=0.37).  Similar 
responses for duration and speed for all four drugs were observed and are reported in 
Table 1.   
Drug Effects on WR in C3H/HeJ Mice 
 Wheel-running distance responses in C3H/HeJ mice (low active) to all four 
drugs are shown in Figure 3.  No significant dose response was seen in distance run 
after treatment with the DAT inhibitor GBR 12783 (p=0.73); however, injection of 
GBR 12783 did significantly increase wheel running i dependent of dose (Fig. 3; 
p=0.0005).  No other drugs used in this study significantly affected wheel running the 
C3H/HeJ mice:  the D1-agonist SKF 81297 (p=0.91), the D1-antagonist SCH 23390 
(p=0.44), and the TH-inhibitor AMPT (p=0.98).  Data for duration and speed for all 
four drugs for C3H/HeJ mice showed similar responses as distance and are reported in 
Table 2. 
Discussion 
 The purpose of this study was to investigate four different dopaminergic acting 
drugs on a high active strain of mice and a low active strain of mice to determine the 
role of D1-like receptors, DAT, and tyrosine hydroxylase in regulating physical activity 
level.  As designed, we observed a significant difference in all baseline wheel running 
indices between C57L/J mice and C3H/HeJ mice but no differences within strain 
between control and experimental groups.  Interestingly, we observed strain dependent 
effects of the D1-like receptor agonist (SKF 81297) and the DAT inhibitor (GBR 
12783).  The D1-like agonist significantly reduced overall distance, duration, and speed 
 87 
 
in C57L/J mice (high active), while the DAT inhibitor significantly increased overall 
distance, duration, and speed in the C3H/HeJ (low active).   Surprisingly, none of the 
drugs increased activity in the high active mice (C57L/J) or decreased activity in the 
low active mice (C3H/HeJ).  
  It is becoming well accepted that a significant genetic component exists in the 
regulation of physical activity in both rodents (69, 142, 149, 153, 262) and humans 
(193).  Since wheel running in mice has been proposed a  a good model for physical 
activity in humans (61, 234), it is warranted to study genetic components of physical 
activity in mice with the probable translation to a human health benefit.  Using wheel 
running as a model of physical activity in mice, both single-gene and epistatic QTL 
associated with physical activity have been found (138, 153).  However, the genes and 
gene interactions involved in the regulation physical activity behavior are still unclear.  
Interestingly, haplotype analysis conducted in the study by Lightfoot and colleagues 
identified a suggestive QTL on chromosome 13 that con ains the Drd1 gene which 
codes for the D1 receptor (153).   In humans, at least one study has suggested that 
DRD2, which codes for the D2 receptor, is associated with physical activity patterns in 
white women (235).  Limited studies are beginning to link genes to physical activity 
phenotypes; however the mechanistic pathways by which t ese genes may function to 
regulate physical activity behavior are not understood. 
 Research by Garland and colleagues presented evidence for a substantial 
genetic/biological influence on physical activity levels in mice (85).  Their results 
suggest central factors such as neurotransmitter systems may be primary in mediating 
the phenotypic differences seen in the selectively bred animals.  For example, Rhodes et 
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al. (200) investigated differences in patterns of brain activity between mice selectively 
bred for high wheel running compared to control mice.  Selectively bred mice, when 
blocked from the wheels, showed increased Fos expression in several areas of the brain 
including the striatum compared to control mice, indicating these areas of the brain may 
be important in motivation for running (200).  Bronikowski et al (29). found that mice 
selectively bred for high wheel running have approximately 20% increased expression 
of D2 and D4 receptors (D1-like receptors were not analyzed in this study) in the 
hippocampus compared to control line mice.  Finally, pharmacological studies with 
mice selectively bred for high wheel running indicate  strong influence of dopamine 
signaling in mediating the difference in running wheel activity between selected 
animals and control line animals (199, 201).  In addition, the dopaminergic influence on 
physical activity appears to be strain dependent.  Several studies in inbred mice have 
shown differential motor responses to dopaminergic acting drugs in different inbred 
strains of mice (32, 33, 194, 228, 238, 239, 261), suggesting genetic differences in the 
dopamine system may mediate behavioral differences in motor response and/or physical 
activity.   
 Similarly, research conducted in our lab (126) indicates C57L/J inbred mice 
(high active) were found have significantly lower expression of Drd1 mRNA as well as 
tyrosine hydroxylase compared to low active C3H/HeJ inbred mice.  Differences in 
expression of key dopamine genes in the striatum and nucleus accumbens between high 
active C57L/J mice and low active C3H/HeJ mice, combined with the data from Rhodes 
and Garland (199), provides evidence for the involvement of the D1-like receptors, as 
well as overall dopamine signaling in the mid-brain in the regulation of physical activity 
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in mice.  Thus, the current study sought to elucidate this possible mechanism further by 
studying the effects of both D1-like agonists and atagonists (both of which affect 
dopamine signaling by manipulation of the receptor), as well as a DAT inhibitor and a 
tyrosine hydroxylase inhibitor (which alter dopamine signaling by manipulating 
presence of dopamine in the synapse) on wheel running distance, duration, and speed in 
differentially active inbred mice. 
Wheel running in response to DAT and Tyrosine Hydroxylase Inhibitors 
 GBR 12783 and AMPT were used in this study to investigate wheel running 
responses to drugs affecting either dopamine re-uptake or dopamine production 
respectively.  The dopamine re-uptake inhibitor inceases the length of time dopamine 
molecules are present in the synapse, while the tyrosine hydroxylase inhibitor would 
theoretically inhibit dopamine production via this enzymatic pathway and essentially 
decrease overall dopamine in the brain. 
Strain dependent responses to GBR 12783 (a dopamine re-uptake inhibitor): 
Strain dependent responses were observed in the current study in response to GBR 
12783.  Specifically, low active C3H/HeJ mice significantly increased wheel running 
distance, duration, and speed independent of dose compared to control mice (Figure 3, 
Table 2).  However, no significant changes in wheel running indices were observed in 
high active C57L/J mice (Figure 2, Table 1).  The fact that C3H/HeJ mice did increase 
wheel running in response to a dopamine re-uptake inhibitor corresponds to previous 
research with animal models of ADHD and treatment with Ritalin, also a dopamine re-
uptake inhibitor.  Differential responses to Ritalin have been shown in both animals 
(201) and humans (98, 203, 219).  Specifically, it has been proposed, that the response 
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to drugs such as Ritalin depends largely on baseline values of the response in question 
(219).  Rhodes and colleagues (2001 and 2003) demonstrated this differential response 
in mice selectively bred for high wheel running (199, 201).  The mice selectively bred 
for high wheel running (“hyperactive mice”) reduced wheel running, while control line 
mice increased wheel running in response to dopamine re-uptake inhibitors.  This same 
differential response is seen in “normal” humans, where re-uptake inhibitors appear to 
increase activity (98), while a decrease in activity in response to re-uptake inhibitors is 
seen in humans diagnosed with ADHD (278).   In the current study, the dopamine re-
uptake inhibitor significantly increased wheel running in C3H/HeJ mice suggesting 
these mice respond similarly as “normal” subjects, and that this particular pathway is 
important in the regulation of physical activity in this strain of mice.   
 Genetic differences in the dopamine system, and thus dopamine signaling in 
response to pharmacological agents, could explain the lack of response to the DAT 
inhibitor in the high active C57L/J mice compared to the increased wheel running 
observed in the low active C3H/HeJ mice.  It has been suggested that synergistic 
activity between D1 and D2 receptors is necessary for normal behavior such as 
locomotion (113, 245, 284) and overall receptor balance may be important to locomotor 
responses (56).  Because C57L/J mice have been shown to have decreased expression of 
both D1 receptors and tyrosine hydroxylase in the mid-brain (126), it is possible that the 
overall balance of D1/D2 in these animals would compensate for an increase in 
dopamine, and thus, override any affects on locomotion by a dopamine re-uptake 
inhibitor.  Thus, even though dopamine signaling should increase due to treatment with 
a DAT inhibitor, the decreased expression of D1 receptors, the decreased dopamine 
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production due to decreased expression of tyrosine hydroxylase, and/or possible 
synergistic compensation from D2 receptors in the C57L/J mice may override any affect 
of a re-uptake inhibitor on wheel running in this strain. 
Wheel Running responses to AMPT (a tyrosine hydroxylase inhibitor):  We 
hypothesized that treatment with AMPT, which would have decreased overall dopamine 
levels would have resulted in an increased activity level.  However, the administration 
of a tyrosine hydroxylase inhibitor did not affect wheel running indices in the low active 
C3H/HeJ mice (Figure 3, Table 2).  However, the only effect of the TH inhibitor was a 
slight, but significant decrease in duration in the high active C57L/J mice (Table 1).  
We observed no significant group by dose interactions f r this drug in C57L/J mice, 
with no difference reflected in distance or speed (Figure 2, Table 1).  In our previous 
study, we observed decreased expression of tyrosine hydroxylase mRNA in the mid-
brain of C57L/J mice compared to C3H/HeJ mice (126).  If decreased expression of 
tyrosine hydroxylase, and subsequent decreased dopamine production and downstream 
dopamine signaling mediate the high active phenotype, inhibiting this enzyme further 
would theoretically lead to further increased physical activity.  However, one 
explanation to why this result was not seen could be that this high active inbred strain is 
already running at a physiological maximum, and any further increase in activity would 
be impossible.  This limitation by a physiological maximum is supported by Rhodes and 
Garland (199) who suggested a possible “ceiling effect” in response to high doses of 
apomorphine in mice selectively bred for high wheel running.  Thus, there is a possible 
“ceiling effect” with the C57L/J mice, in that antagonist treatment may not increase 
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wheel running because these mice cannot physiologically increase distance, duration, or 
speed significantly higher than baseline.  
 Strain differences in tyrosine hydroxylase activity have been shown previously 
(266, 267), suggesting genetic background may be important in baseline tyrosine 
hydroxylase activity and subsequent behavioral effects.  Genetic differences in baseline 
tyrosine hydroxylase activity could explain why C3H/HeJ mice did not respond to 
AMPT treatment.  In the current study, C3H/HeJ mice did increase wheel running in 
response to a dopamine re-uptake inhibitor, which in reased the available pool of 
dopamine for signaling in the mid-brain.  However, inhibiting tyrosine hydroxylase in 
these mice would essentially decrease the pool of available dopamine for signaling, 
which would theoretically induce an opposite response (e.g. decreased wheel running).  
However, it is also possible there is a “floor effect” in the low active C3H/HeJ mice.  
The concept of a floor effect is supported by other studies that show that even when all 
factors are controlled and the effects of sex hormones are removed, in spite of a marked 
decrease in daily activity, there is a baseline mini um below which the mice will not 
become ‘less active’ (i.e. activity levels can not be reduced to zero, RS Bowen, personal 
correspondence).  Given that the activity levels of the C3H/HeJ mice we observed are 
similar to the minimum baseline levels observed by controlled, gonadectomized mice, 
we suggest that the C3H/HeJ may naturally be running at a physiological floor, and any 
drug induced reductions in wheel running may not be possible.  Thus, genetic 
differences in dopaminergic signaling between high active C57L/J mice and low active 
C3H/HeJ mice – strains of mice that were intentionally chosen for this investigation due 
to their marked differences in activity levels as compared to the standard reference 
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strain C57Bl/6J (149) - may be mediating differential responses to both dopamine 
increases and decreases resulting in undetectable responses due to physiological 
“ceiling/floor” effects.  
Wheel running in response to D1-like agonist and antagonist 
 In contrast to determining the response to generaliz d alteration in dopamine 
levels through the use of reuptake inhibitors or dopamine synthesis inhibitors, we used 
SKF 81297 (D1-like agonist) and SCH 23390 (D1-like antagonist) to investigate the 
affects of manipulation of dopamine signaling specifically through the D1-like 
receptors.  Previous research from our lab suggested that expression of D1 receptors 
were significantly decreased in the striatum and nucleus accumbens in C57L/J mice 
compared to C3H/HeJ mice independent of wheel running exposure (126).   
Strain dependent responses to SKF 81297 (a selective D1-like agonist):  With 
the application of a D1-like receptor agonist, the dopamine signaling should increase, 
thus, hypothetically decreasing activity levels if the D1 receptors are involved in 
regulation of activity.  We confirmed this hypothesis in only the C57L/J mice with the 
significant reduction in distance, duration, and speed.  However this D1-like receptor 
agonist had no effect on wheel running indices in C3H/HeJ mice (Figures 2 and 3, 
Tables 1 and 2).  Evidence from our lab indicates that reduced function of the D1-like 
receptors in high active inbred C57L/J mice is at le st partly explained by reduced 
expression of these receptors in the mid-brain compared to other low active inbred 
strains (126).  It has also been suggested that mice selectively bred for high wheel 
running have reduced function of D1-like receptors, but not the D2-like receptors (199).  
Thus, our observation that high active C57L/J mice in the current study reduced wheel 
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running in response to a D1 agonist supports the hypot esis that decreased function of 
D1-like receptors may mediate running wheel activity in high active inbred strains.   
 In contrast to the high active strains, the low active C3H/HeJ mice did not 
decrease wheel running in response to the D1 agonist used in this study.  However, two 
plausible explanations could explain this differential strain response to the D1 agonist.  
First, as mentioned previously, it is possible thate low active C3H/HeJ strain may 
already run at a physiological “floor”.  If this were the case, any drug treatment 
hypothesized to decrease activity levels (e.g. D1-agonist, TH inhibition) would not 
decrease wheel running any lower than baseline.  Secondly, the D1-receptor pathway is 
likely not the only pathway regulating low activity n this strain.  Others have shown 
strain dependent responses in locomotion to different dopamine acting drugs (32, 33, 
228, 238, 239, 261, 266) and differences in dopaminerg c anatomy between strains has 
also been demonstrated (70).  Further, other investigators have suggested that low 
activity may be a different phenotype than high activity and thus, probably has differing 
regulating mechanistic pathways (JT Lightfoot, personal correspondence).  Thus, due to 
differences in genetic make-up of C3H/HeJ mice, it is possible that regulation of 
physical activity in this low active inbred strain is still mediated in part by the dopamine 
system, but regulated through different pathways compared the clear D1-like receptor 
regulation of physical activity in C57L/J mice.   
 Wheel running responses to SCH23390 (a selective D1-like antagonist): Given 
the evidence of the importance of D1-like receptors in regulating the high active 
phenotype in C57L/J mice, we hypothesized that a D1-like antagonist would further 
increase wheel running in this strain by blocking the inhibitory D1-like receptors in the 
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mid-brain.  However, SCH 23390 (a selective D1-like antagonist) had no significant 
effect on wheel running in C3H/HeJ mice, and only a slight effect on duration in 
C57L/J mice in the current study (Figure 2 and 3, Tables 1 and 2).  However, we do not 
believe that this slight change in duration in the C57L/J mice is physiologically 
significant because post-hoc analysis did not reveal any significant group by dose 
interactions suggesting that the overall main effect significant difference was seen only 
when data from all four doses were combined.  Additionally, no differences in distance 
or speed were found after administration of the D1 antagonist in C57L/J mice indicating 
that the difference in duration did not significantly affect total distance.  Thus, in spite 
of the effect of the D1-agonist in reducing activity, the earlier proposed “ceiling effect” 
in the C57L/J mice when given a dopamine reuptake inhib tor may also be active with 
the administration of the D1-like antagonist.   
 The low active C3H/HeJ mice did not increase wheel running in response to the 
D1 antagonist which was similar to the response seen when these mice were given the 
D1-like agonist.  As we suggested earlier, it is posible that signaling through other 
pathways in the dopamine system is able to “compensat ”, and thus the D1 receptors 
may not be the primary signaling pathway through which physical activity responses of 
low active C3H/HeJ mice are regulated. 
Summary  
 Strain differences in the response to a D1 receptor ag nist demonstrate that D1-
like receptors may play a role in mediating the high active phenotype in C57L/J mice.  
Likewise, differential strain responses to a dopamine re-uptake inhibitor suggest that the 
amount of dopamine present in the synapse may be important in mediating the low 
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active phenotype in C3H/HeJ mice.  However, full elucidation of the role of 
dopaminergic functioning in these strains purposely ected for their divergent activity 
responses is difficult because of the possibility of physiological ceiling and floor effects 
in physical activity levels.  Thus, genetic differenc s in dopamine signaling between 
inbred strains are a potential explanation for the diff rences in wheel running responses 
to dopaminergic drugs.     
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Figure 1:  Baseline values of distance, duration, and speed in control and experimental 
      mice 
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Figure 1:  A.  Running wheel data at baseline for C57L/J mice (n=7) is shown.  No 
difference in distance (km) (p=0.52), duration (mins) (p=0.52), or speed (m/min) 
(p=0.74) were found between control and experimental groups; however, C57L/J mice 
ran significantly farther, longer, and faster than C3H/HeJ mice at baseline (p<0.0001).  
B.  Running wheel data at baseline for C3H/HeJ mice (n=8).  No differences in distance 
(p=0.22), duration (p=0.23), or speed (p=0.44) were found between control and 
experimental groups. 
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Figure 2: Distance responses to all four dopaminergic drugs in C57L/J mice. 
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Figure 2:  Distance responses to all four drugs in the C57L/J mice.  A.  Dose response 
after administration of SKF 81297 is shown.  No signif cant dose response was seen; 
however, all four doses significantly reduced wheel running distance in experimental 
mice compared to controls (p=0.0004).  B Dose response to SCH 23390 is shown.  No 
significant changes in distance run between groups were seen for any dose (p=0.12).  C
Dose response to GBR 12783 is shown.  No significant differences in distance run were 
seen between groups for any dose (p=0.89).  D. Dose response to AMPT is shown.  No 
significant differences in distance run between group was seen for any of the doses 
(p=0.37). 
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Figure 3:  Distance responses to all four dopaminergic drugs in C3H/HeJ mice. 
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Figure 3:  Distance responses to all four drugs in the C3H/HeJ mice.  A.  Dose response 
after administration of SKF 81297 is shown.  No signif cant differences in distance 
between groups were seen for any dose (p=0.91).  B.  Dose response to SCH 23390 is 
shown.  No significant changes in distance run betwe n groups were seen for any dose 
(p=0.44).  C.  Dose response to GBR 12783 is shown.  No significant dose response 
was observed, however, distance was significantly icreased in the experimental group 
compared to control following treatment with all four doses (p=0.0005).  D. Dose 
response to AMPT is shown.  No significant differenc s in distance run between group 
was seen for any of the doses (p=0.98). 
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Table 1:  Duration and speed responses to dopaminergic drugs in C57L/J mice 
 
Drug Dose (mg/Kg) Duration (mins/12hrs) Speed (m/min) 
    Control Experimental Control Experimental 
SKF 81297 0.5 425±13 358±82 33.3±4.4 29.1±5.7 
 0.75 416±17 327±65 32.5±4.5 25.3±4.6 
 1 389±50 346±69 33.3±7.7 25.7±5.8 
 1.25 401±13 294±45 31.4±5.4 28.3±3.6 
  p=0.002* p=0.015* 
      
SCH 23390 0.5 396±63 312±47 28.5±4.1 28.2±5.4 
 0.75 389±45 324±42 28.7±3.7 30.0±5.7 
 1 395±29 364±15 29.0±2.8 31.1±5.3 
 1.25 402±41 371±24 29.7±3.0 30.7±3.1 
  p=0.003* p=0.54 
      
GBR 12783 15 392±12 382±35 28.4±4.0 33.1±3.5 
 20 375±27 339±39 28.4±4.5 31.9±4.2 
 25 431±24 369±70 29.3±2.4 28.4±1.3 
 30 378±10 373±60 28.5±3.4 28.5±2.0 
  p=0.091 p=0.18 
      
AMPT 85 341±28 343±36 28.6±4.6 30.9±4.0 
 90 362±27 320±82 29.6±3.4 30.7±2.8 
 95 396±25 323±67 31.0±2.4 32.0±3.1 
 100 392±37 342±40 30.6±2.5 32.2±4.2 
  p=0.043* p=0.29 
      
  
 
Table 1:  Duration and speed data for C57L/J mice.  p values reported indicate 
significant differences between group within strain.   
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Table 2:  Duration and speed responses to dopaminergic drugs in C3H/HeJ mice.   
 
Drug 
Dose 
(mg/Kg) Duration (mins/12hrs) Speed (m/min) 
    Control Experimental Control Experimental 
SKF 81297 0.5 97±106 73±33 15.2±4.8 17.2±2.6 
 0.75 83±111 75±56 14.4±3.6 16.4±2.6 
 1 101±145 103±56 14.5±4.2 16.5±2.8 
 1.25 104±150 124±99 15.0±4.4 17.1±2.9 
  p=0.95 p=0.11 
      
SCH 23390 0.5 95±133 74±79 15.7±5.0 16.0±2.8 
 0.75 110±141 84±78 15.3±5.5 16.3±2.5 
 1 111±142 91±80 15.6±4.6 16.3±2.9 
 1.25 110±147 89±80 15.5±5.6 16.1±2.6 
  p=0.56 p=0.63 
      
GBR 12783 15 20±16 66±41 12.5±1.4 16.3±1.7 
 20 21±14 53±36 12.5±1.0 15.4±2.0 
 25 19±12 69±25 12.1±1.2 16.4±1.8 
 30 23±19 53±15 13.1±1.0 15.7±1.1 
  p=0.0005* p<0.0001* 
      
AMPT 85 39±43 35±12 14.3±3.4 15.3±1.6 
 90 34±32 36±6 14.1±2.9 15.0±1.3 
 95 33±30 35±10 14.2±2.7 15.3±1.4 
 100 29±26 37±15 15.3±3.0 15.5±1.6 
  p=0.82 p=0.31 
      
  
 
Table 2:  Duration and speed data for C3H/HeJ mice.  p values reported indicate 
significant differences between group within strain. 
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APPENDIX A 
siRNA TECHNOLOGY TO KNOCK-DOWN 
GENES INVOLVED IN PHYSICAL ACTIVITY 
 
 
 As mentioned throughout this dissertation, the use of knock-out animals is not 
always ideal in that deleterious side effects of completely knocking out a gene would 
likely obscure the true functions of the gene of interest with relation to the phenotype in 
question.  This is particularly apparent with the genes coding for the dopamine 
receptors.  Knock-out of the D1 and D2 receptors causes severe developmental 
problems in mice.  Recently, the development of technology that allows for transient 
knock-down of a gene holds promise in the study of gene function in all areas of 
science.  The process of RNAi (RNA interference) in animals was originally reported in 
1998 by Fire and Mello (71).  Since then, several methods have been developed to try 
and use this process to selectively knock-down expression of a gene of interest.  This 
appendix will briefly summarize pilot studies from our lab using siRNA (short 
interfering RNA) techniques to knock-down genes of interest in mice in vivo.  Although 
early studies using siRNA in our lab were not successful, this technology (and methods 
of administration) are constantly evolving, and will hopefully be useful in future studies 
of genes involved in the regulation of physical activity in mice. 
  
Hydrodynamic Tail Vein Procedure 
 In-vitro work with siRNA has been widely successful, but in-vivo silencing 
using this technology is typically hindered by unsuccessful delivery methods.  Several 
methods using siRNA in combination with a vector have been developed.  These 
techniques include but are not limited to lipid-siRNA complexes (220), cationic 
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polymer complexes with siRNA (95), plasmids, and viral vectors.  Although these 
techniques have been used with limited success, access to these types of vectors was a 
limiting factor in our lab.  Delivery of “naked siRNA” (just the siRNA nucleotide 
sequence without a vector) has also been studied, and several techniques including local 
delivery, intranasal/inhalation, and hydrodynamic tail vein procedure have been used 
with some success in rodents.  We decided to attemp the hydrodynamic tail vein 
procedure (292) in a small number of mice to target knockdown of Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH, a typical housekeeping gene), and lipoprotein 
lipase (LPL). 
 
Method A:  The hydrodynamic tail vein procedure is described in etail in the protocol 
for TransIT Delivery Solution (Mirus Bio, Madison, WI).  Briefly, siRNA (Dharmacon 
Inc., Chicago, IL) targeting GAPDH, and LPL were mixed with TransIT Delivery 
Solution (1ug/mL).  This solution was administered via the tail vein in a volume of 3mL 
in less than 10 seconds.  Two mice received experimental injections (siRNA targeting 
LPL), while one mouse received a control injection (siRNA targeting GAPDH).  2 days 
after injections, mice were sacrificed and tissues w re harvested.  Liver mRNA 
expression was analyzed using semi-quantitative PCR.  The liver is the most likely 
tissue to take up siRNA after systemic injection, thus we investigated liver mRNA 
levels first.  Ultimately we were interested in knocking-down the gene in muscle tissue. 
Results Method A:  No differences were seen in mRNA expression in the liver for 
either gene between mice receiving siRNA and mice with no injections, suggesting this 
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method was unsuccessful in silencing the GAPDH gene, or the LPL gene (data not 
shown).   
Comments Method A:  It was extremely difficult to inject that much volume into the 
tail vein in less than 10 seconds.  In fact in some mice the injection needed to be split 
into 3 separate injections using a smaller gauge needle. 
 
Method B:  In our second attempt to use siRNA to knock-down ge es in vivo in mice, 
we used two different strategies in combination with the methods described above.  
First, we increased the dose of siRNA to 40ug/mL.  Second, we also exercised a group 
of the mice on the treadmill immediately following injection in hopes that more blood 
circulation would stimulate more uptake of the siRNA in the tissues.  Because of 
technical difficulties using the large volume for the hydrodynamic tail vein procedure 
we also tried simple intraperitoneal (IP) injections using 40ug/mL siRNA in a volume 
of 0.5mL TransIT solution injection in a separate group of mice.  Thus, in these 
procedures 2 mice received the standard hydrodynamic tail vein procedure (siRNA 
targeting GAPDH, 40ug/mL) [one of these mice was run on the treadmill immediately 
following recovery from injection (approx. 15 min)].  Additionally, 2 mice received 
0.5mL IP injection of siRNA targeting GAPDH (40ug/mL) [one of these mice was run 
on the treadmill immediately following injection (approx. 15 min)].  Tissues were 
harvested 2 days post injections and liver and muscle mRNA levels were evaluated 
using semi-quantitative PCR. 
Results Method B:  No differences in mRNA expression of GAPDH in liver or muscle 
tissue was found between siRNA injected animals vs. controls, or between animals who 
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ran on the treadmill following injection vs. animals who did not run, in either the 
hydrodynamic tail vein method, or the IP injection method (Data not shown). 
Comments Method B:  At this point we were very disappointed; however research in 
the literature does show that knock-down methods in vivo are quite difficult using 
standard methods.  The main hurdle remains getting the tissues to take up the siRNA.  
Thus we decided to try a different method of delivery. 
 
Method C:  We attempted a transient isolation hind limb procedure in which we 
attempted to systemically deliver the siRNA via thefemoral vein, however we were 
unable to successfully complete this procedure in mice.  Thus, we ended up trying direct 
intra-muscular injections of siRNA targeting GAPDH in TransIT Solution.  Two mice 
were injected with siRNA (10ug/mL) directly into the ind limb muscle in the right leg 
(left leg muscle was used as control).  Additionally, 3 mice were injected with siRNA 
(40ug/mL) directly into the hind limb muscle of the right leg (left leg control).  Tissue 
was harvested two days post injection and muscle GAPDH mRNA levels were assessed 
using semi-quantitative PCR. 
Results Method C:  Results of direct intra-muscular injection of siRNA targeting 
GAPDH at a low concentration, and a high concentration are illustrated in Figure 1 
below. 
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Figure 1:  Knock-down of GAPDH in hind limb muscle using direct intra-muscular 
       injection of two different doses. 
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Figure 1:  No differences were found between the injected leg muscle, and control leg 
muscle using 10ug/mL injection of siRNA (p=0.81).  However, 40ug/mL siRNA 
injected intra-muscularly significantly reduced GAPDH expression (p=0.03) in muscle 
tissue. 
 
Conclusions Method C:  Knocking down GAPDH using direct intra-muscular injection 
of high doses of siRNA in TransIT Solution appears to be possible.  However, at lower 
doses no differences were observed.  Thus, intra-muscular injection of high doses of 
siRNA may be useful in knocking down genes of interest in muscle tissue only.  As 
apparent in the figure however, the knock-down, although statistically significant, may 
not have been biologically significant.  Only a 19% reduction in expression was 
achieved. 
 
Overall Conclusions 
 These studies demonstrate the already known fact th t siRNA knock-down of 
genes in vivo is a difficult and delicate process.  Limited resources in our lab prevented 
us from studying further more complicated methods of gene knock-down using siRNA 
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technology.  It is certainly possible that in the future siRNA may be used to study the 
role of the dopamine genes in regulation of physical a tivity, however direct injection 
into the brain is not a current option for these genes in mice.  Thus, siRNA targeting 
methods for gene knock-down in brain tissue need to be developed to further study the 
role of genes located in brain tissue. 
